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Endoscopic dacryocystorhinostomy 
has become accepted treatment for 
patients with saccal and post-saccal 
obstructions of the lacrimal system. 
In this study the surgical outcome 
after two endoscopic dacryocystorhi-
nostomy surgical techniques, with 
and without the use of lacrimal 
silicone tubes were investigated. In 
addition, the relationship between 
the preoperative conditions of nasal 
mucosa and final outcome of surgery 
was evaluated. This dissertation also 
provides new information about ef-
fect of preoperative changes in nasal 
mucosa on surgical outcome and the 
role of heat shock protein 47 (HSP47) 
expression in scar formation of the 
nasal mucosa.
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ABSTRACT
Tearing  and  recurrent  or  chronic  conjunctival  discharges  are  the  most  frequent  symptoms  of  lacrimal
pathway obstruction. The conservative treatments relieve the complaint only temporarily, thus surgery is the
treatment of choice. Dacryocystorhinostomy has been accepted as the best treatment for patients with
obstructions  of  the  lacrimal  system  on  the  level  of  the  sac  (saccal  obstruction)  or  below  it  (post-saccal
obstruction). The aim of this operation is to create a bypass between the lacrimal sac and the nasal cavity. For
many years, external dacryocystorhinostomy (EXT-DCR) has proven to be an efficient surgical method and
thus  it  represents  the  gold  standard  for,  less  invasive  surgical  techniques.  During  the  last  two  decades,
endoscopic dacryocystorhinostomy (EN-DCR) has become accepted as a suitable treatment for patients with
saccal and post-saccal obstruction of the nasolacrimal system.
The present work includes retrospective (36 patients) and prospective (64 patients) clinical studies. The aims
of  this  trial  were to  evaluate  the overall  surgical  outcome after  EN-DCR,  to  assess  the outcomes after  two
EN-DCR surgical techniques, with and without the use of lacrimal silicone tubes, to explore the impact of
successful primary EN-DCR on the quality of life and symptoms, and to investigate the effect of
preoperative  changes  in  nasal  mucosa  on  surgical  outcome  and  the  role  of  heat  shock  protein  47  (HSP47)
expression in scar formation of the nasal mucosa.
This  study shows that  EN-DCR is  an effective and safe  procedure for  patients  with saccal  and post-saccal
obstruction of the nasolacrimal pathway, with an 89% success rate. EN-DCR had benefical effects on the
symptoms  and  on  the  quality  of  life  (QoL)  of  the  patients,  and  silicone  stenting  after  primary  EN-DCR
proved to be unnecessary. Preoperative histopathological analysis of the nasal mucosa over the lacrimal sac
demonstrated that squamous metaplasia and strong expression of HSP47 of the nasal mucosa independently
or together predict a poor outcome after EN-DCR. The exact timing for the assessment of surgical outcome is
difficult  but  this  study shows that  the last  follow-up for  the final  outcome assessment  should be one year
rather than six months.
National Library of Medicine Classification: WO 505, WW 208
Medical Subject Headings (MeSH): Dacryocystorhinostomy; Endoscopy; HSP47 Heat-Shock Proteins;
Lacrimal Duct Obstruction/surgery; Metaplasia; Nasal Mucosa; Nasolacrimal Duct; Silicones;
treatmentoutcome; Adult; Humans; Quality of Life,Questionnaires
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Itä-Suomen Yliopiston Julkaisuja. Terveystieteiden tiedekunnan väitöskirjat. 18. 2010. 83 s.
TIIVISTELMÄ
Kyynelvuoto ja silmien rähmiminen ovat yleisiä ja kiusallisia ongelmia kyynelteiden tukoksesta kärsiville
potilaille. Konservatiivisella hoidolla oireet saadaan pysymään poissa jonkin aikaa, mutta leikkaushoidon
teho on todistetusti parempi. Kyyneltieleikkauksessa nenän ja kyynelpussin väliin tehdään aukko (avanne),
jolloin kyynelteiden alaosan tukos ohitetaan ja kyynelneste pääsee esteettä poistumaan nenäkäytävän
puolelle. Perinteisenä leikkausmenetelmänä on käytetty ulkoista kyyneltiekirurgiaa, jossa avanne
kyynelpussista nenäonteloon muodostetaan nenän tyveen tehtävän ihoviillon kautta. Viime vuosina
tähystystekniikan kehityksen myötä nenän kautta (tähystämällä) suoritettavat, vähemmän traumaattiset
leikkaukset ovat yleistyneet.
Väitöstutkimuskokonaisuus muodostuu 36 retrospektiivisen ja 64 prospektiivisen potilaan aineistosta, joille
suoritettiin tähystysleikkaus pitkittyneen kyyneltietukoksen vuoksi Kuopion Yliopistollisessa sairaalassa.
Väitöstutkimuksessa selvitettiin kyynelteiden tähystysleikkauksen vaikutusta pitkittyneen
kyyneltietukoksen hoidossa sekä silikoniputkien käytön tarpeellisuutta leikkauksen yhteydessä. Lisäksi
arvioitiin nenän limakalvon stressiproteiinin (HSP47) merkitystä leikkaustulosta ennustavana tekijänä,
leikkauksen jälkitarkastusten ajoituksen merkitystä sekä leikkaushoidon vaikutusta potilaiden
elämänlaatuun ja oireisiin.
Tutkimustulokset osoittivat, että kyynelteiden tähystysleikkaus on tehokas ja turvallinen toimenpide.
Leikkauksen seurauksena kyyneltietukoksesta aiheutuneet oireet hävisivät nopeasti ja lisäksi potilaat
kokivat yleistä elämänlaadun paranemista. Silikoniputken käyttö leikkauksessa osoittautui tarpeettomaksi.
Lisäksi havaittiin, että nenän limakalvon tulehdusmuutoksilla ja HSP47:n vahvalla ilmentymisellä on yhteys
nenänsisäisen kyyneltieleikkauksen epäonnistumiseen. Leikkaustulosten arviointi tulisi suorittaa
aikaisintaan vuoden kuluttua leikkauksesta.
Luokitus: WO 505, WW 208
Yleinen suomalainen asiasanasto (YSA): kyynelkanavan ahtauma; tähystys; elämänlaatu
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1 INTRODUCTION
Obstruction of the nasolacrimal pathway is a common disorder, especially in elderly
patients, clinically manifested by the presence of tearing and/or infection (Woog
2007). The symptoms of nasolacrimal duct obstruction (NLDO) were described in
papyrus documents by the ancient Egyptians (Hirschberg 1982), but still relatively
little information is available concerning the epidemiology of this problem.
Only two published epidemiological studies concerning lacrimal pathway disorders
are found in the literature. In 1967, Dalgleish (Dalgleish 1967) reported that the
incidence of nasolacrimal pathway disorder in the population aged over 40 years was
10-14%, but at the age of 90 years it was 40%. Forty years later, Woog (Woog 2007)
published a study concerning the epidemiology of acquired symptomatic lacrimal
obstruction and showed that the most common form of acquired symptomatic
lacrimal obstruction is NLDO, occurring with an annual incidence rate of 0.02%. The
same study also confirms that acquired lacrimal pathway obstruction was most
common in the middle-aged, with a median age of 67 years. Moreover, 69% of
patients with all forms of obstructions and 73% with NLDO were female.
When conservative treatments are ineffective, the definitive treatment for this
problem is surgery in which the patency of the nasolacrimal pathway is restored. An
endonasal approach to correct the NLDO was first reported by Caldwell (Caldwell
1893). The popularity of an endonasal approach has been limited due to the technical
difficulties involved in visualizing the surgical site and removing soft and bony
tissues. Therefore, for one hundred years, after the report by Toti (Toti 1904), lacrimal
bypass surgery was performed more commonly using an external approach, and the
outcomes justify this. However, during the last two decades the advances in rigid
endoscopic equipment and other instruments have made it possible to obtain more
information about the anatomical landmarks of the nasolacrimal system, leading to
less invasive and safer endoscopic techniques.
During the last eight years, an average of 500 lacrimal pathway operations have been
performed annually in Finland (KuntaHilmo 2009). However, the suitability of and
2outcomes after different techniques of lacrimal surgery have not been established.
Moreover, little is known about patient satisfaction after these interventions.
The present trial compared overall results after EN-DCR in a retrospective study. For
comparison of outcome after primary EN-DCR with and without silicone tubes, a
prospective study was also conducted. In addition, the relationship between the
preoperative conditions of nasal mucosa and final outcome of surgery was
investigated.
32 REVIEW OF THE LITERATURE
2.1 Anatomy of the lacrimal system
The system that secretes and drains tears into the nasal cavity consists of the lacrimal
gland, the upper and the lower lacrimal pathway. The upper lacrimal pathway
consists of the puncta and lacrimal canaliculi, whereas the lower lacrimal pathway
consists of the lacrimal sac and nasolacrimal duct. The nasolacrimal duct includes a
bony part. The anterior part of the bony pathway is formed by the frontal process of
the maxilla, and posteriorly by the lacrimal bone (Duke-Elder 1961).
2.1.1 Lacrimal gland
The lacrimal gland lies beneath the superior temporal margin of the orbital bone in
the lacrimal fossa of the frontal bone. A palpable lacrimal gland is usually a sign of a
pathologic change such as dacryoadenitis. The tendon of the levator palpebrae
muscle divides the lacrimal gland into a larger orbital part (two-thirds) and a smaller
palpebral part (one-third). Several tiny accessory lacrimal glands (glands of Krause
and Wolfring) located in the superior fornix secrete additional serous tear fluid
(Duke-Elder 1961).
2.1.2 Puncta and canaliculi
Tears enter the lacrimal system through the punctal openings at the medial ends of
the inferior and superior eyelids, then flow along the canaliculus and the common
canaliculus into the lacrimal sac and down the nasolacrimal duct into the nose under
the inferior turbinate (Figure 1). The inferior canaliculus punctal opening is slightly
larger in diameter (0.3mm) than the superior (0.2mm) and about 70% of the tears
enter the inferior canaliculus and 30% through the superior. The punctal openings
are surrounded by a ring of connective tissue, and normally remain patent. Both the
upper and lower puncta are situated on a slight elevation at the groove formed by
the plica semilunaris and the eyeball (Allen 1951).
4The canaliculi are also surrounded by muscle fibers of the lacrimal portion of
Horner’s muscle (musculus orbicularis oculi), which form the constrictor muscle of
the lacrimal punctum. The length of the horizontal portion of the canaliculi is
approximately 8 mm in the upper eyelid and 10 mm in the lower eyelid. At the
medial canthal angle after passing behind the medial canthal tendon, the upper and
lower canaliculi join to form the common canaliculus, which is 3-5 mm long. The
common canaliculus dilates before penetrating the lacrimal sac fascia, termed the
sinus of Maier. A fold of mucous membrane is found at the junction between the
common canaliculus and the lacrimal sac, termed the Valve Rosenmuller (Aubaret
1908).
Figure 1. Anatomy of the nasolacrimal sysytem
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1. Lacrimal gland                                6. Lacrimal sac
2. Punctal openings 7. Nasolacrimal duct
3. Inferior canaliculus                         8. Uncinate process
4. Superior canaliculus                       9. Middle turbinate
5. Common canaliculus                     10. Inferior turbinate
52.1.3 Lacrimal sac
The lacrimal sac varies in size from 12 to 14 mm vertically, 4 to 8 mm
anteroposteriorly, and 2 to 4 mm in width (Groell et al. 1997, Orhan et al. 2009b). It is
lined by double-layered ciliated pseudostratified epithelium. Underneath the
epithelium there are a basement membrane and a submucosa layer containing some
serous glands (Rivas et al. 1991). The surrounding fibrous tissue contains elastic
fibers, supplied by a venous plexus that transforms the layer into erectile tissue
continuous with that underlying the nasal mucosa (Duke-Elder 1961). The
subepithelial tissue consists also of many nerve endings (Tsuda 1952).
2.1.4 Nasolacrimal duct
The nasolacrimal duct (NLD) is a continuation of the lacrimal sac. The membranous
part of the nasolacrimal duct extends under the inferior turbinate approximately 15
mm from the tip of the inferior turbinate and 30-35 mm from the lower margin of the
nostril.  The opening of  the  nasolacrimal  canal  is  oval  in  cross-section and 3  mm in
diameter. The bony canal of the nasolacrimal duct is formed by the ethmoid, lacrimal
and maxillary bones, and is 12 mm in length. Hassner’s valve, which is a mucosal
flap forming the medial wall of the membranous duct, prevents reflux into the
lacrimal drainage passage. The nasolacrimal duct is composed of the substantia
propria and two epithelial layers that are very similar to those of the lacrimal sac
(Schaeffer 1922, Paulsen et al. 2003, Orhan et al. 2009a).
The intranasal orifice of the NLD is located approximately 25 mm from the anterior
nasal spine, 14 mm from the nasal floor, and 15 mm from the anterior attachment of
the inferior nasal concha. The NLD passes superiorly and anteriorly from the orifice
to the anterior attachment of the middle nasal concha (Tatlisumak et al. 2010).
62.1.5 The lateral nasal wall
The lateral nasal wall (Figure 2) is formed by nasal turbinates, which are bony and
lined by mucosa. The structures of the lateral wall are the middle turbinate, middle
meatus, uncinate process, agger nasi, and ethmoidal bulla. The maxillary line is a
ridge  of  the  lateral  nasal  wall  which  lies  anterior  to  the  insertion  of  the  middle
turbinate (axilla) (McDonogh and Meiring 1989). The middle turbinate is a part of the
ethmoid bone. The uncinate process is a bony plate located anterior to the middle
turbinate with mucosal covering. The agger nasi is a bony protrusion anterior to the
insertion of the middle turbinate. The bulla ethmoidalis is a rounded projection of the
lateral nasal wall beneath the middle turbinate. The middle meatus is the opening
between the middle and inferior turbinate adjacent to the fossa lacrimalis (Rebeiz et
al. 1992, Watkins et al. 2003).
Figure 2. Anatomy of the lateral nasal wall
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1. Maxillary line                                                6. Lacrimal bone
2. Frontal process of maxilla                           7. Middle turbinate
3. Axilla of the middle turbinate                    8. Ethmoidal bulla
4. Agger nasi       9. Inferior turbinate
5. Superior turbinate                                      10. Uncinate process
72.1.6 The lacrimal fossa
The lacrimal fossa (Figure 3) lies in the medial orbital wall behind the orbital rim
which  is  10  to  17  mm  vertically,  3  to  8  mm  in  horizontally  and  2  to  4  mm  antero-
posteriorly. The frontal process of the maxillary bone and lacrimal bone forms part of
the lacrimal fossa. It is bound in front by the anterior lacrimal crest (part of the
maxilla), which is adjacent to the inferior orbital rim and behind the posterior
lacrimal crest (part of the lacrimal bone).  The floor of the lacrimal bone is very thin
with an average thickness of 0.06 mm (McDonogh and Meiring 1989, Woog et al.
1993, Hartikainen et al. 1996).
The position and configuration of the fossa varies substantially. Bisaria examined 240
orbits of 120 skulls and showed that in 20% of the orbits the anterior lacrimal crest
was well-defined but the posterior lacrimal crest was ill-defined (Bisaria et al. 1989).
Figure 3. Anatomy of the lacrimal fossa
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1. Posterior lacrimal crest
2. Lacrimal fossa
3. Anterior lacrimal crest
4. Frontal process
82.2 Physiology of the lacrimal system
2.2.1 Lacrimal gland
The lacrimal gland receives its sensory supply from the lacrimal nerve. Its
parasympathetic secretomotor nerve supply comes from the nervus intermedius
(nerve of Wrisberg). The lateral and posterior motor roots of the facial nerve
containing parasympathetic fibers course to the lacrimal gland via the greater
superficial petrosal nerve which synapses in the sphenopalatine ganglion (Figure 4).
The sympathetic fibers arise from the superior cervical sympathetic ganglion and
follow the course of the blood vessels to the gland (Calkins 1964).
Figure 4. Innervation of the lacrimal gland.
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1. Lacrimal gland
2. Lacrimal nerve
3. Trigeminal nerve
4. Facial nerve
5. Greater petrosal nerve
6. Sphenopalathine ganglion
7. Parasympathetic fibers
92.2.2 Tear secretion
The tear film that moistens the conjunctiva and cornea consists of three layers:  an
oily layer, which prevents rapid desiccation, a watery layer, which ensures that the
cornea remains clean and smooth for optimal transparency and a mucin layer, which
like the oily outer layer stabilizes the tear film (Wolff 1946, Wolff 1954). As the
eyelids close, they act like a windshield wiper to move the tear fluid medially across
the eye toward the puncta and lacrimal canaliculi. With its hydrophobic properties, it
prevents rapid evaporation like a layer of wax (Bron et al. 2002).
The outer oily layer (approximately 0.1 m thick) is a product of the meibomian
glands and the sebaceous glands and sweat glands of the margin of the eyelid. The
primary function of this layer is to stabilize the tear film (Mishima and Maurice 1961,
King-Smith et al. 1999). The middle watery layer (approximately 8-10 m thick) is
produced by the lacrimal gland and the accessory lacrimal glands (glands of Krause
and Wolfring), and it cleans the surface of the cornea and ensures mobility of the
palpebral conjunctiva over the cornea and a smooth corneal surface for high-quality
optical images (Bron et al. 2002). The inner mucin layer (approximately 0.8 m thick)
is secreted by the goblet cells of the conjunctiva and the lacrimal gland. It is
hydrophilic with respect to the microvilli of the corneal epithelium, which also helps
to stabilize the tear film. This layer prevents the watery layer from forming beads on
the cornea and ensures that the watery layer moistens the entire surface of the cornea
and conjunctiva (Holly and Lemp 1971, Holly 1973).
Lysozyme, beta-lysin, lactoferrin, and immunoglobulin A are tear-specific proteins
that give the tear fluid antimicrobial characteristics. The normal human tear pH
ranges from 6.5 to 7.6 (Abelson et al. 1981).
2.2.3 Tear elimination
Tear outflow includes an active lacrimal pump mechanism by contraction of the
orbicularis eye muscle with blinking (Jones 1957), and distension of the sac, a
mechanism governed by a system of helically arranged fibrillar structures and the
action of epithelial secretion products (Thale et al. 1998). The physical factors include
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capillarity, gravity, respiration, evaporation, and absorption of tear fluid through the
lining epithelium of the efferent tear ducts (Paulsen et al. 2003).
The lumen of the lacrimal sac and the nasolacrimal duct is surrounded by the
vascular plexus. This network  of  large  vessels  is  connected  caudally  with  the
cavernous body of the nasal inferior turbinate (Thale et al. 1998, Paulsen et al. 1998).
Paulsen and co-workers (Paulsen et al. 2000) hypothesized that the surrounding
vascular plexus is comparable to a cavernous body. In addition to regulating the
blood flow, it is thought that the specialized blood vessels permit the opening and
closing of the lumen of the lacrimal passage, effected by the expanding and subsiding
of the cavernous body, and simultaneously control tear outflow. The cavernous body
of the efferent tear ducts innervation protects the ocular surface against foreign
bodies (Paulsen et al. 2003).
2.3 Obstruction of the nasolacrimal pathway
Patients with symptomatic obstruction of the nasolacrimal pathway are commonly
encountered in clinical practice, but the true incidence of this problem is difficult to
determine. A recent epidemiological study from Minnesota showed an annual
incidence rate up 0.03% and the mean age 61 years for all forms of acquired
symptomatic lacrimal obstructions (Woog 2007).
2.3.1 Obstruction of the upper lacrimal system
Obstruction of the puncta lacrimalis
Obstruction of  the  puncta  lacrimalis  can be  congenital,  or  acquired,  but,  there  is  no
uniform grading system in the literature for different degrees and severity of
punctual stenosis (Cahill and Burns 1991).
Congenital external punctal occlusion has been defined as either the absence of both
punctum and papilla or imperforation of the punctum (Hurwitz 1990).
Acquired external punctual stenosis (AEPS) may result from various infections, lid
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malposition, trauma, tumors and toxic effects of topical and system medications
(McNab 1998, Lee et al. 1998, Weston and Loveless 2000, Esmaeli et al. 2001). Ageing
can  be  also  a  risk  factor  of  punctual  stenosis  (Kristan  1988).  Some  studies  have
reported an association between canaliculi and nasolacrimal duct stenosis or
obstructions with AEPS (Colla et al. 1994, Weston and Loveless 2000, Esmaeli et al.
2001). In a prospective study, Kashkouli and co-workers (Kashkouli et al. 2003),
examined the causes of symptomatic AEPS and assessed the frequency of associated
canalicular and nasolacrimal ducts obstruction with AEPS. In this study a significant
association between the nasolacrimal duct stenosis and obstruction with AEPS after
the age of 70 years was found.
Obstruction of the canaliculus
The causes which lead to obstruction of the canaliculus may be divided into primary
(suppurative inflammations) and secondary (non-suppurative inflammations)
canaliculitis (Tabbara 1982).
Infections of the canalicular system of the eye are rare and often misdiagnosed. These
infections are most common in postmenopausal women and are ascribed to
hormonal changes, which probably decrease tear productions predispose to infection
(Hussain et al. 1993, Vecsei et al. 1994). The most common cause of this infection is
Actinomyces species (Hussain et al. 1993). Inflammation leads to the formation of a
dacryolith that obstructs the lacrimal duct (Vecsei et al. 1994).
 Cases of primary (suppurative) canaliculitis should be distinguished from secondary
forms, which may be caused by herpes simplex virus (Harris et al. 1981, Williams et
al. 1985), varicella (Sanke and Welham 1982), trachoma (Tabbara and Bobb 1980),
erythema multiforme (Williams et al. 1985), or topical (Laibson 1973) or systemic
medications (Caravella et al. 1981).
The secondary forms (non-suppurative) of canaliculitis result in punctal and
canalicular stenosis, pericanalicular scarring and finally obstructions (Laibson 1973,
Caravella et al. 1981, Harris et al. 1981, Sanke and Welham. 1982, Williams et al.
1985).
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2.3.2 Obstruction of the lower lacrimal system
2.3.2.1 Primary acquired nasolacrimal duct obstruction
Primary acquired nasolacrimal duct obstruction (PANDO) comprises about two
thirds of the cases with stenosis, and the pathogenesis is unknown. The process is
characterized by gradual inflammation and subsequent fibrosis of the nasolacrimal
duct, which leads to increasing obstruction of the drainage system (Bartley 1993,
Önerci 2002).
Predisposing factors: sex and age of the patient
The etiology of PANDO is unknown. Several predisposing factors have been
suggested, including cigarette smoking, middle-face trauma,  and  a  history  of
dacryocystitis. PANDO occurs more frequently in post-menopausal women (Zolli
and Shannon 1982, Linberg and McCormick 1986, Tarbet and Custer 1995a). It is
possible that the greater prevalence of PANDO in female subjects is caused by the
bony nasolacrimal canal's smaller diameter The lower nasolacrimal fossa and the
middle bony lacrimal duct are smaller in females than in males, and a narrow bony
nasolacrimal canal predisposes to the development of lacrimal duct obstruction
(Groessl et al. 1997). Janssen and co-workers (Janssen et al. 2001) reported that female
subjects had a significantly smaller minimum diameter (on average 0.35 mm). The
smaller diameter in female subjects can cause tear fluid stasis and infections from the
nasal cavity, since the bony nasolacrimal canal is flatter in females than in males.
Shigeta and co-workers (Shigeta et al. 2007) found that the caliber of the bony
lacrimal duct and the angle between the bony lacrimal duct and the nasal floor
generally increased with age, primarily before the age of 40 years. Thus, the
narrowness of the bony nasolacrimal canal and the acute angle between the bony
canal and the nasal floor in females predispose to chronic inflammation of the
nasolacrimal drainage system. The individual structural features such as the drain
lines from the frontal and ethmoidal sinuses, the anatomically narrow and high
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infundibulum and septal deviation may play an important role in the inflammatory
processes in NLD (Önerci 2002).
Nasal cavity and paranasal sinus conditions
The relationships of the nasolacrimal pathway with the lateral nasal wall and
paranasal sinuses make it vulnerable to inflammation and subsequent obstruction by
various pathologies of the nose and paranasal sinuses (Wong et al. 1998). Early
reports associated inflammatory sino-nasal diseases with almost 50% of nasolacrimal
duct obstructions (Garfin 1942). Acute infections in the nasal cavity and recurrent
and chronic infections of the paranasal sinuses have been suggested to lead to
spreading the infection through the nasolacrimal duct, followed by mucosa
inflammation, swelling, scar formation and finally stenosis (Önerci 2002).
2.3.2.2 Secondary acquired nasolacrimal duct obstruction
Secondary acquired nasolacrimal duct obstruction (SANDO) in adults may result
from a wide variety of specific infections, or inflammatory, neoplastic, traumatic or
mechanical causes (Linberg and McCormick 1986, Bartley 1992).
Bartley (Bartley 1992) reported that the most common causes of bilateral SANDO are
Actinomyces infection, sarcoidosis, cicatrical pemphigoid, Steven Johnson syndrome
and allergy, whereas Herpes zoster, Adenovirus and Aspergillus may cause unilateral
SANDO. Wong and co-authors (Wong et al. 1998) show that bilateral SANDO
without facial trauma and sinonasal surgery history may indicate unusual systemic
diseases such as sarcoidosis, Wegener granulomatosis and chronic lymphocytic
leukemia. Jokinen and Kärjä (Jokinen and Kärjä 1974) showed that nasal allergy,
lupus vulgaris and non-specific nasal infections may cause inflammation in the
nasolacrimal system. Some investigators have suggested that the inflammation and
fibrosis  may  be  secondary  to  coexisting  bacterial  infectious  colonization  within  the
lumen of the lacrimal sac (Huber-Spitzy et al. 1992, DeAngelis et al. 2001). The
progressive atrophy of the nasal mucosa leads to underlying bone inflammation, and
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eventually to infection, fibrosis and later mechanical obstruction of the NLD (Singh
et al. 2004).
Tumors of the nasolacrimal system usually mimic a unilateral inflammation of the
lacrimal sac and may lead to a delay in definitive diagnosis (Ryan and Font 1973).
The most common presenting signs and symptoms of lacrimal tumors are tearing,
and recurrent inflammation of the sac or lacrimal sac mass (Hornblass et al. 1980,
Stefanyszyn et al. 1994). Bloody discharge form the eye may occur in a patient with
lacrimal sac melanoma (Yamade and Kitagawa 1978). A review of the literature
discloses that 50% of malignant nasolacrimal system tumors relapsed within 5 years
(Harry and Ashton 1969, Ryan and Font 1973, Khalil and Lorenzetti 1980, Ni et al.
1982). Malignant epithelial neoplasms often recur locally, and can metastasize and be
fatal (Stefanyszyn et al. 1994).
SANDO may occur as a result of nasoethmoidal, nasal, or midfacial fractures, or
repair of other midfacial injures (Osguthorpe and Hoang 1991). Sinus and
rhinoplastic surgery has a potential risk of damage of the nasolacrimal system
(Osguthorpe and Calcaterra 1979, Serdahl et al. 1990). A significant internal
mechanical cause of SANDO may be dacryoliths (Baratz et al. 1991), which occur in
three times as frequently in females as males (Jones 1965, Herzig and Hurwitz 1979,
Berlin et al. 1980). SANDO may also result from external compression of the
paranasal sinuses mucoceles, which commonly involves more than one sinus on the
same side and commonly occurs in the fronto-ethmoidal and/or maxillary sinuses
(Russell et al. 1985, Ormerod et al. 1987, Ajaiyeoba et al. 2006).
2.3.3 Congenital nasolacrimal duct obstruction
Congenital nasolacrimal duct obstruction affects up to 20 % of newborns (MacEwen
et al. 2001). Honavar and co-workers (Honavar et al. 2000) observed two types of
congenital nasolacrimal obstructions membranous (77%) and firm (23%), and
demonstrated than infants with firm obstruction have a poor prognosis. Fortunately,
spontaneous resolution of symptoms of nasolacrimal obstruction occurs in
approximately 90-96% of cases during the first years of life (MacEwen et al. 2001).
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2.3.4 Microbiology of the normal conjunctival flora
Several studies have examined normal ocular flora and found bacteria and fungi.
Martins and co-workers (Martins et al. 2004) examined the bacterial conjunctival
flora in diabetic and nondiabetic patients, without ocular symptoms In the 60
nondiabetic patients, coagulase negative Staphylococcus was identified in 62%,
Cornebacterium in 39%, Staphylococcus aureus in 12%, and Pseudomonas aeruginosa in
3% of cases. In another study of normal conjunctival flora coagulase negative
Staphylococcus was found in 100%, Diphteroids in 43% and Staphylococcus aureus in
24% of cases (Gritz et al. 1997). In a large study of Indian bacterial and fungal flora of
the normal conjunctiva, 86 % were culture positive for bacteria and 12% were culture
positive for fungi: the most common bacterial isolates were Staphylococcus albus and
Staphylococcus aureus. The most common fungal isolates were Aspergillus, Mucor, and
Penicillium (Tomar et al. 1971).
2.3.5 Clinical manifestations of obstruction of the nasolacrimal pathway
Epiphora is the most prevalent symptom of obstruction of the nasolacrimal system
(Önerci 2002). The term epiphora comes from the Greek word epifora, which in turn is
derived from the root words epi (upon) and ferein (to bring). Epiphora as an isolated
symptom may occur in patients with dry eye syndromes, allergical conjunctivits,
punctual or canalicular acquired obstruction, lacrimal dysgenesis, abnormalities of
lid position or movement, lacrimal pump failure, or obstruction of nasolacrimal
pathway (Moss et al. 2000, MacEwen et al. 2001, Butrus and Portela 2005). The
obstruction results in stasis of tears in the lacrimal sac and subsequently infection
with an accumulation of mucopurulent discharge and inflammation (Huber-Spitzy et
al. 1992).
Dacryocystitis is the most frequent disorder of the lower lacrimal system. In most
cases it is the result of obstruction of the nasolacrimal duct, and is usually unilateral
(Huber-Spitzy et al. 1992). In acute dacryocystitis, stenosis within the lacrimal sac
leads to retention of tear fluid and subsequently to bacterial infection. Clinical
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symptoms include painful swelling and redness in the lacrimal sac region (Huber-
Spitzy et al. 1992, Das et al. 2008). The pain may be in the forehead, nose, and teeth.
An abscess in the lacrimal sac may develop due to acute dacryocystitis: it can rupture
the skin and drain though the fistula (Lee and Woog 2001).
Chronic  dacryocystitis  is  an  inflammatory  condition  of  the  lacrimal  sac  which  is
associated with an obstruction of the nasolacrimal duct due to dilatation of the
lacrimal sac, or chronic inflammation of the connective tissue or nasal mucosa
(Russell et al. 1985, Huber-Spitzy et al. 1992). The initial characteristic of chronic
dacryocystitis is increased lacrimation and in many cases chronic unilateral
conjunctivitis (McEwen 1997, Das et al. 2008). No signs of inflammation are usually
present, but on applying pressure to the inflamed lacrimal sac, a purulent discharge
regurgitates through the punctum (Boruchoff and Boruchoff 1992).
2.3.6 Microbiology of dacryocystitis
The spectrum of bacterial isolates in acute and chronic dacryocystitis is similar. The
most common isolates in dacryocystitis are Pseudomonas aeruginosa, Staphylococcus
aureus, Enterobacter aerogenes, Citrobacter, Streptococcus pneumoniae, Escherichia coli, and
Enterococcus. (Briscoe et al. 2005, Kubal and Garibaldi 2008).
The spectrum of microorganisms of acute and chronic dacryocystitis varies in
different geographical areas and shows a different predominance of the species.
Reports from Finland (Hartikainen et al. 1997), North America (DeAngelis et al.
2001), China (Sun et al. 2005), Australia (Sainju et al. 2005) and Saudi Arabia
(Chaudhry et al. 2005) show a predominance of either Staphylococcus aureus or
Staphylococcus epidermis. Reports from India show a predominance of Streptococcus
pneumonia, Staphylococcus aureus and Staphylococcus epidermis (Badhu et al. 2006,
Bharathi et al. 2008). A study from Israel (Briscoe et al. 2005) showed a predominance
of Pseudomonas aerugenosa.
To characterize the differences between acute and chronic infection, Mills and co-
workers (Mills et al. 2007) conducted a prospective study and showed that Gram-
positive organisms were much more common than Gram-negative organisms
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overall, and the proportions did not differ significantly between the groups.
Moreover, methicillin-resistant Staphylococcus aureus was associated with acute
dacryocystitis more often than with chronic dacryocystitis.
The high rate of pathogenic fungi in conjunctival flora such as Fusarium, Aspergirum,
Mucor and Actinomyces species may play a role in the microbiological characteristics
of dacryocystitis and overall ocular morbidity (Hussain et al. 1993, Sun et al. 2004,
Capriotti et al. 2009).
2.3.7 Histopathology of the nasolacrimal pathway
Inflammation with a combination of varying degrees of fibrosis is the most common
histopathological finding in patients with PANDO (Linberg and McCormick 1986).
Paulsen (Paulsen 2003) showed that early-stage dacryostenosis is characterized by
active inflammation and edema of the epithelial and subepithelial tissue. Goblet cells
and subepithelial seromucous glands revealed signs of hypersecretion. The chronic
stage of dacryostenosis is characterized by loss of differentiated epithelial cells from
thin epithelium to basal cell hyperplasia, which is associated with squamous
metaplasia. Descending inflammation from the eye or ascending inflammation from
the nose induces swelling of the mucous membrane, rearrangement of connective
tissue fibers, malfunctions in the subepithelial cavernous body and temporary
occlusion of the lacrimal pathway. Subsequently, epithelial changes can lead to total
fibrous obstruction of the lumen (Paulsen 2003). The absence of Goblet cells and the
presence of fibrosis and epithelial ulcerations indicate the intensity of the lacrimal sac
inflammation (Lee-Wing and Ashenhurst 2001, Bernardini et al. 2002, Anderson et al.
2003, Ciftci et al. 2005).
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2.4 Evaluation of obstruction of the nasolacrimal pathway
2.4.1 Clinical history and examination
The  clinical  history  of  the  patient  is  essential  information.  Obstruction  of  the
nasolacrimal pathway may be due to previous nasolacrimal duct intubation,
recurrent infections in lacrimal pathway and paranasal sinus, midfacial trauma
(Osguthorpe and Hoang 1991), lacrimal and orbital operations, sinonasal surgery
(Osguthorpe and Calcaterra 1979), or radiotherapy (Baratz et al. 1991) of head and
neck regions, and specific inflammatory diseases may also cause obstruction of the
nasolacrimal pathway (Vasquez et al. 1988).
The ophthalmologist is the primary consultant for patients with disorders of the
lacrimal duct. There are two main reasons for tearing: epiphora and dry eye.
Epiphora is a result of a disorder of tear drainage caused by mechanical obstruction
or  lacrimal  pump  failure.  The  dry  eye  is  due  to  either  tear  film  watery  component
production deficiency or increased evoparative loss, which results in irritation of the
cornea and reflective excessive tearing by hypersecretion (Mathers and Laine 1998).
The basic examination includes inspection and slit-lamp microscopy of the ocular
surface and eyelids. Inspection of the puncta for poor position, narrowing or stenosis
may suggest canaliculitis. Palpation and inspection of the lacrimal sac region may
reveal dacryocystitis, mucocele, or abscess. If rhinogenic causes of the obstruction are
suspected, patients should be referred to an otorhinolaryngologist (Guzek et al.
1997). However, the goal of the basic examination is to differentiate between
epiphora and dry eye (Kohn 1988, Moss et al. 2000).
2.4.2 Evaluation of tear formation
The Shirmer tear test provides information about the quantity of the watery
component in tear secretion (Foulks 2008). This test is performed by inserting a strip
of paper into the conjunctival sac of the temporal third of the lower eyelid. The result
is considered normal if after 5 minutes, at least 15 mm of the paper turns blue due to
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the alkaline tear fluid, and abnormal if the amount is less than 5 mm (Schirmer 1903).
Tear break-up time (TBUT) evaluates the stability of the tear film. This test is
performed by the instillation of fluorescein dye (10 L of a 0.125% fluorescein
solution) to the precorneal tear film. The eye is observed using a slit lamp and cobalt
blue filter  during the  blink cycle.  Tear  film break up under  the  10  seconds notes  as
sign of dry eye. Tear break-up time of at least 10 seconds is considered normal
(Cedarstaff and Tomlinson 1983).
2.4.3 Evaluation of tear drainage
Primary and Secondary Jones Dye Tests
The Primary Jones test is positive if a 20 mg/mL fluorescein sodium solution instilled
into the inferior fornix can be detected after five minutes under the inferior turbinate.
It indicates that the nasolacrimal passage is unobstructed. The Primary Jones test is
negative if no fluorescein is found in the inferior meatus of the nasal cavity (Guzek et
al. 1996). The Secondary Jones test is positive if fluorescein is detected, showing that
it had entered the sac after syringing. The Secondary Jones test is negative if no dye is
detected after syringing (Wobig and Wirta 1998). The disadvantage of these tests is
that they cannot differentiate the physiological from the anatomical causes, and
cannot localize the level of obstruction. Moreover, there is a high false negative rate
(e.g., 22% of normal patients will have no dye in the nose) and the test does not
identify patients with a partial obstruction of the nasolacrimal system (Hurwitz and
Welham 1975).
Probing and irrigation
Diagnostic probing and syringing of the lacrimal pathway are sufficient for
evaluating the function of the lacrimal drainage system or to determine the location
and extension of obstructions in patients with epiphora. After the application of a
topical anesthetic, a conical probe is used to dilate the punctum. Then the lower
lacrimal system is irrigated with physiologic saline solution through a blunt cannula.
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If the nasolacrimal pathway is open, the solution flows freely into the nose.
Canalicular stenosis results in reflux through the irrigated punctum. If the stenosis is
in  the  common  canaliculis  or  deeper  in  the  post-saccal  region,  reflux  will  occur
through the opposite punctum (Figure 5) (Calkins 1964).
Figure 5. Location of obstruction by irrigating of the lower lacrimal system.
1
2
3
4
1. No obstruction
2. Pre-saccal obstruction (stenosis of the inferior canaliculus)
3. Pre-saccal obstruction (stenosis of the commmon canaliculus)
4. Saccal or post-saccal obstruction (stenosis within the lacrimal sac or nasolacrimal
duct)
Lacrimal duct endoscopy
Fine endoscopes give direct visualization of the mucous surface of the lower
nasolacrimal system. Dacryoscopy was described by Cohen (Cohen et al. 1979) as a
supplement of other diagnostic tests. However, up to now, endoscopic examination
of the lower lacrimal system has not been a routine procedure (Önerci 2002).
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2.4.4 Imaging of the nasolacrimal pathway
Dacryocystography
Radiographic contrast studies have established the shape, position and size of the
pathway and the level of obstruction to drainage. Radiographic contrast material is
instilled in the same manner as the saline solution through the lacrimal system.
Installation of the contrast material can generate high pressure in the nasolacrimal
system, which may open a partial obstruction (Wearne et al. 1999).
Radionuclide dacryoscintigraphy
Radionuclide dacryoscintigraphy using 99mTc may provide information about
physiological function involving tear drainage transit time (Rossomondo et al. 1972).
The limitation of this procedure is the relatively minimal morphological information
and the large variation of normal tear transit times (Robertson et al. 1979).
Computed tomography
Computed tomography (CT) shows excellent contrast between bony structures and
soft tissue. Thin-section CT is an effective imaging modality to evaluate the
structures related to the nasolacrimal system, paranasal sinuses and the surrounding
soft tissue (Russell et al. 1985, Groell et al. 1997).
Computed tomography dacryocystography
Computed tomography can be combined with radiographic contrast medium. This
method is useful for characterizing the membranous lacrimal passage and the bony
structures. Moreover, it gives information about the anatomical and functional
condition of the nasolacrimal pathway (Ashenhurst et al. 1991).
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Magnetic resonance imaging
Magnetic resonance imaging (MRI) is an accessible method to identify anatomic
abnormal variations such as divertucula and septa, to differentiate masses, and
evaluate postoperative changes in the lacrimal sac. Nonetheless, conventional MRI
has a low sensitivity in distinguishing between lacrimal sac diverticulum and
neoplasm (Önerci 2002).
Dynamic magnetic resonance dacryocystography
Magnetic resonance dacryocystography (MR-DCG) is suitable for assessing drainage
problems of the nasolacrimal duct system and gives additional information
concerning the surrounding soft tissue structures, but is not recommended as a
routine examination (Goldberg et al. 1993, Kirchhof et al. 2000). In contrast to other
imaging techniques, dynamic (dMD-DCG) does not involve ionizing radiation, or
require the use of chemical contrast media. Moreover, it provides information about
the level of obstruction in the NLD, and has a sensitivity of 91% and a specificity of
90% in the evaluation of the nasolacrimal system patency (Cubuk et al. 2010).
2.5 Treatment of obstruction in adults
2.5.1 Medical therapy
Ophthalmic infections can cause damage to the structure of the eye and if left
untreated can lead to vision loss and even blindness (Snyder and Glasser 1994).
Although treatment guidelines of ocular infections recommend laboratory culture for
the determination of the causative pathogen, in practice the initial choice of antibiotic
therapy is generally made without knowledge of the pathogen (Snyder and Glasser
1994, Callegan et al. 2007). The penicillins, cephalosporins and fluoroquinolones, as
bactericidal agents, are generally used to treat ocular infections. Bacteriostatic drugs
such as macrolides, chloramfenicol, and sulfonamides are used in cases in which
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there in a specific benefit or history of allergy (Mulligan and Cobbs 1989, Bertino
2009).
The most common ocular infection is bacterial conjunctivitis, which is self limiting
and presents as an acute infection or as a symptom of chronic dacryocystitis (McCord
and Doxanas 1990, Rose 2007). The recommended treatment of dacryocystitis is
topical and systemic antibiotics to cover penicillinase-producing staphylococcal
bacteria (Bourcier et al. 2003). Some studies suggest parenteral administration in
addition to topical antibiotics as a standard therapy for dacryocystitis (Snyder and
Glasser 1994).
To avoid the development of antibiotic resistance it is important to modify the
antibiotic therapy based on the laboratory culture, sensitivity results and patient’s
response (Briscoe et al. 2005).
2.5.2 Surgical treatments for saccal and post-saccal obstructions
2.5.2.1 External dacryocystorhinostomy
Dacryocystorhinostomy is an operative treatment to relieve epiphora by creating a
free communication between the lacrimal sac and nasal cavity. Toti, in 1904, was the
first to propose a method for EXT-DCR (Toti 1904). His technique was to expose the
lacrimal sac by an external skin incision, remove the medial wall, punch out a piece
of bone using a hammer and chisel, resect a corresponding area of the nasal mucous
membrane and sew up the external wound. At that time, like today, the main cause
of failure was the formation of granulation tissue. Toti suggested removing part of
the middle turbinate bone to enlarge the size of the bony window. In 1914, an
improvement of this technique, suturing a flap of nasal mucosa to the periostium,
was made by Kuhnt. In 1920, Ohm suggested suturating the margins of the nasal
mucosa to the lacrimal sac (Hughes 1986). The modern method was described by
Dupuy-Dutemps and Bourguet in 1921 (Hallum 1948). They suggested incising the
posterior wall without removing tissue and approximating flaps of lacrimal sac and
nasal mucosa. This technique had a high success rate, and for a long time it was the
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gold-standard operation performed by ophthalmologists (Hughes 1986, Werb 1986).
To prevent closure of the rhinostoma, Gibbs (Gibbs 1967) introduced silicone tubing,
which was used by Quickert and Dryden (Quickert and Dryden 1970) to intubate the
nasolacrimal sac after EXT-DCR.
2.5.2.2 Evolution of endonasal dacryocystorhinostomy
Caldwell described an endonasal procedure in 1893 (Caldwell 1893). In 1910 an
endonasal approach was attempted by West, who introduced the idea of a window
osteotomy by removal of the lacrimal bone and the superior maxilla to assess the
nasolacrimal duct (West 1914). This technique was modified in 1914 Halle, who also
introduced the idea of mucosal-periost flaps to ensure a permanent rhinostoma
between the lacrimal sac and nasal cavity (Halle 1914).
Bumsted and colleagues (Bumsted et al. 1982) found that a small healed ostium could
provide an excellent functional result and suggested that the size of the surgical
anastomosis is not directly related to the success of the procedure. Based on this
information, physicians increased the use of endoscopy in lacrimal surgery and Rice
(Rice 1988), in a cadaver study, demonstrated that endoscopy is a viable option for
DCR. The first modern endonasal approach was described by McDonogh and
Meiring (McDonogh and Meiring 1989).
Endonasal DCR can also be performed using an operating microscope. The
advantage of this technique is operative precision by allowing for bimanual work
(Hausler and Caversaccio 1998, Dietrich et al. 2003). Favorable results using a
microscopic endonasal DCR technique have been obtained in children and adults
with lacrimal sac distention, acute abscesses in the lacrimal sac, and saccal and post-
saccal obstructions (Dietrich et al. 2003).
In 1990, Massaro and co-workers (Massaro et al. 1990), in a cadaver study,
introduced endonasal laser-assisted DCR, using argon blue green laser for bone
removal. Shortly thereafter carbon dioxide (CO2) and potassium-titanyl phosphate
(KTP)/neodyuium-yttrium-garnet (YAG) lasers were approved for lacrimal
endonasal surgery (Gonnering et al. 1991). In 1992, Levin and StormoGipson (1992)
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introduced endocanalicular laser-assisted DCR in a cadaver study. In 1995, Javate
and colleagues (1995) introduced a modified endoscopic laser-assisted technique
using a radiofrequency device for incision of the mucosa and bone.
Currently, endonasal approaches can be divided into endonasal laser assisted DCR
(Gonnering et al. 1991, Hehar et al. 1997), endocanalicular laser assisted DCR
(Pearlman et al. 1997), and powered mechanical endonasal DCR or “cold steel” DCR,
with (Sham and van Hasselt 2000) or without (Cokkeser et al. 2000) drills.
2.5.2.3 Endoscopic endonasal dacryocystorhinostomy
EN-DCR is a minimally invasive procedure with improved endoscopic
instrumentation. Moreover, EN-DCR has many advantages over EXT-DCR,
including the preservation of the pumping mechanism of the orbicularis muscles,
avoidance of the external scar and injury of the medial canthus, reduced of operative
time, intraoperative hemorrhage, postoperative morbidity, and postoperative
recovery time, and the possibility of performing additional sinonasal surgery at the
same time when needed (Boush et al. 1994, Weidenbecher et al. 1994, Eloy et al. 1995,
Sham and van Hasselt 2000). Also, an acute infection in the lacrimal sac is not a
contraindication for endoscopic surgery (Eloy et al. 1995, Lee and Woog 2001).
However, some studies have reported that relatively high equipment costs and a
significant learning curve are notable disadvantages of EN-DCR (Metson 1990, Kong
et al. 1994).
Indications
Primary EN-DCR is indicated in the management of epiphora and infection related
to PANDO/SANDO associated with specific inflammatory or infiltrative disorders,
when the obstruction site is in the lacrimal sac or the nasolacrimal duct (Unlu et al.
2000, Woog et al. 2001, Önerci 2002). Moreover, EN-DCR is useful in the
management of PANDO/SANDO associated with previous surgery in the nasal
cavity, paranasal sinuses or trauma of the middle face (Osguthorpe and Calcaterra
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1979, Osguthorpe and Hoang 1991, Sham and van Hasselt 2000, Weidenbecher et al.
1994). In addition, EN-DCR may be appropriate in children with congenital
dacryostenosis including nasolacrimal duct cyst formation (Cunningham and Woog
1998). EN-DCR is also indicated in revision surgery following previous external or
endonasal DCR (Hausler and Caversaccio 1998, Szubin et al. 1999, El-Guindy et al.
2000).
Contraindications
The contraindications of EN-DCR are associated with the suspicion of lacrimal
system neoplasia or in patients in whom neoplasia cannot be excluded (Reifler 1993,
Bartley 1994, Javate et al. 1995). It has also been reported that lacrimal sac mucocele
extending into the eyelid may not be drained using an intranasal approach (Boush et
al. 1994, Sprekelsen and Barberan 1996). The obstructions in the upper (pre-saccal)
part of the nasolacrimal system such as punctal and canalicular stenosis are also
contraindication of using EN-DCR (Eloy et al. 1995, Sham and van Hasselt 2000,
Unlu et al. 2000).
Patient selection
EN-DCR is an effective treatment for patients with saccal and post-saccal obstruction
of the lacrimal pathway (Sprekelsen and Barbera 1996). Some studies show that EN-
DCR  provides  a  good  result  in  patients  with  functional  obstruction  of  the
nasolacrimal system (Mannor and Millman 1992, Wormald and Tsirbas 2004). It has
been demonstrated that EN-DCR is an effective procedure for resolving symptoms
with a good success rate in patients with acute purulent dacryocystitis with abscess
formation (Lee and Woog 2001, Wu et al. 2009a).
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Preoperative examination and imaging
Investigation of the lacrimal system should begin with an examination of the upper
lacrimal  system  to  exclude  agenesis,  stenosis  or  ectropium  of  the  punctum,  and
palpation of the canthal area to exclude a mucocele, dacryolith or tumor. Lacrimal
system irrigation should be performed to confirm anatomical obstruction. Careful
evaluation of the nasal cavity using an endoscope is crucial to assess the possible
technical problems that can make EN-DCR more difficult (Wormald 2002).
Contaminant infections of the paranasal sinuses and nasal cavity are a potential risk
of failure for EN-DCR, so treating these preoperatively is generally recommended
whenever possible (Allen et al. 1988).
A considerable proportion of patients with epiphora will have a patent nasolacrimal
system  on  syringing,  which  raises  the  question  of  what  is  the  most  appropriate
preoperative examination for patients with functional nasolacrimal duct obstruction
(Wearne et al. 1999).
 Radiological studies suggest CT or CT-DCG to determine the level of nasolacrimal
pathway obstruction, the thickness of the bone surrounding the lacrimal sac, and the
presence of nasal and paranasal sinuses abnormalities, and to facilitate the planning
of possible adjunctive procedures at the time of EN-DCR (Russell et al. 1985, Whittet
et al. 1993, Sham and van Hasselt 2000).
2.5.2.4 Key points in the success of endonasal dacryocystorhinostomy
In the last two decades, EN-DCR outcomes have been compared with EXT-DCR
outcomes. A review of the literature reveals a success rate of 70-99% for EN-DCR
(Allen and Berlin 1989, Ben Simon et al. 2005, Yigit et al. 2007, Leong et al. 2010b).
The following steps of EN-DCR are recognized in the literatures as being important
in minimizing failures.
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Anesthesia and preparation of the nose
EN-DCR can be performed under general or local anesthesia with intravenous
sedation (Howden et al. 2007). Some authors suggest general anesthesia in patients
with  acute  dacryocystitis  or  difficult  nasal  anatomy  with  tight  access,  and  if  the
patient prefers it, but generally local anesthesia is recommended (McDonogh and
Meiring 1989, Smith et al. 2001, Meyer 2000, Durvasula and Gatland 2004).
Ciftici (Ciftci et al. 2005) compared the effectiveness, complications, and patient
acceptance of local anesthesia with general anesthesia in young patients for EXT-
DCR and showed that postoperative nausea and vomiting (PONV), length of
hospital stay, and intraoperative bleeding were reduced in the local anesthesia
group. In a study with 66 patients Smith and co-workers (Smith et al. 2001) reported
a new lacrimal fossa block, combined with standard intranasal local anesthesia. They
showed that this technique can achieve a direct contact with the periosteum of the
frontal process of the maxilla within the lacrimal fossa, which provides good
intraoperative analgesia.
Regardless of the type of anesthesia, vasoconstriction of the nasal mucosa and
anterior ethmoidal and sphenopalatinal nerve block using cocaine or a solution of
lidocaine with adrenalin are always carried out preoperatively. The combination of
vasoconstriction of the nasal cavity using a long-action decongestant and local
anesthetic is effective for outpatient dacryocystorhinostomy, and helps visualization
and minimizes intraoperative bleeding (Meyer 2000).
In cases performed under local anesthesia, topical ocular anesthetic is instilled in the
operative eye and infiltrated local anesthetic solution in the medial canthal region
and medial portion of the eyelid. However, serious ocular complications have
resulted from local anesthesia for DCR, including ocular perforation associated with
a medial peribulbar block (Kersey et al. 2001), and a moderate retrobulbar
hemorrhage resulting from a medial peribulbar local anesthetic infiltration (McNab
and Simmie 2002).
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Localization of the lacrimal sac
When anatomic landmarks of the lateral nasal wall are altered or do not exist, the
lacrimal sac is difficult to find (McDonogh and Meiring 1989). Christensen (1951)
introduced the idea of transillumination for visualizing the lacrimal sac localization
in dacryocystorhinostomy by using an endoilluminator probe introduced through
the canaliculis into the lacrimal sac. Today, endoillumination, as a method for
identification for localization of lacrimal sac, is widely use in many endoscopic
techniques (Massaro et al. 1990, May et al. 2002, Wormald 2002).
Many authors claim that the axilla of the middle turbinate is a landmark for the roof
of the lacrimal sac (McDonogh and Meiring 1989, Sprekelsen and Barberan 1996).
However,  Wormald  and  co-authors,  in  a  study  with  47  CT-DCG   patients,  showed
that the major part of the lacrimal sac (10 mm) is situated above the axilla of the
middle turbinate, extending 1-2 mm below this landmark (Wormald et al. 2000)
(Figure 6).
Figure 6. Localization of the lacrimal sac
1 2
3
4
5 6
7
1. Roof of the lacrimal sac                             5. Uncinate process
2. Axilla of the middle turbinate                  6. Middle turbinate
3. Superior turbinate                                      7. Inferior turbinate
4. Nasolacrimal duct
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Mucosal incision and flaps
Tsirbas and Wormald (Tsirbas and Wormald 2003) recommend making a cut in the
mucosa superiorly above the insertion of the middle turbinate on the lateral nasal
wall and anterior to the axilla and vertically down the frontal process of the maxilla.
To avoid trauma of neighboring tissue, the rectangular incisions of nasal mucosa
should be made using a scalpel blade (Wong et al. 1998, Tsirbas and Wormald 2003)
and the nasal mucosal flap must include the periosteum (Önerci 2002).
The main task in EN-DCR is to create the largest possible bony ostium to completely
expose the medial wall of the lacrimal sac, and to achieve contact between the
lacrimal sac and the nasal mucosa. In the earliest studies, this was achieved by
suturing (Welham and Wulc 1987). Later, Eloy (Eloy et al. 1995) suggested stapling
with titanium clips. More recently, Wormald (Wormald 2002) and Tsirbas (Tsirbas
and Wormald 2003) describe an approach where the lacrimal sac is fully exposed and
marsupialized into the lateral nasal wall of the nose with nasal and lacrimal mucosa
apposition. This is a one of the most important keys to the success of EN-DCR.
Location of the osteotomy
 Welham and Wulc (Welham and Wulc 1987) suggest the removal of all the bone
between the medial wall of the lacrimal sac and axilla to achieve an ideal ostium. On
the other hand, some authors advocate leaving approximately 5mm free of bone
around the canaliculus, at the junction of the middle turbinate and the lateral nasal
wall, as a landmark of the floor of the lacrimal fossa (Whittet et al. 1993). Other
authors have recommended developing a larger ostium by removing the frontal
process of the maxilla involving the anterior lacrimal crest and superiorly above the
attachment of the middle turbinate to remove bone covering the fundus of the
lacrimal sac (Boush et al. 1994, Weidenbecher et al. 1994, Sham and van Hasselt 2000,
Tsirbas and Wormald 2003). Moreover, it has been claimed that a larger osteotomy
with complete sac exposure provides better access to the nasal cavity and reduces the
incidence of failure (Mann and Wormald 2006). However, in the literature it seems
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that the success rate has been similar whether the osteotomy was larger or smaller
than 10 mm in diameter (Beigi et al. 1998).
Rhinostoma size
Some authors consider the ostium size to be non-significant (Linberg et al. 1982), and
have suggested creating a small ostium involving the inferior portion of the lacrimal
bone (Massaro et al. 1990, Tutton and O'Donnell 1995). In contrast, Önerci (Önerci
2002) suggested removing as much as possible of the medial wall of the lacrimal sac.
Metson (Metson 1990) advised the enlargement of the rhinostoma to a diameter of 10
mm, allowing free passage of a lacrimal probe into the nasal cavity through both
canaliculi. To prevent the development of sump syndrome, some authors suggest
performing “terminal” or “inferior” EN-DCR, in which a relatively small ostium is
created by marsupialization of only the inferior portion of the lacrimal sac and the
adjacent duct into the nose (Yung and Hardman-Lea 1998, Mortimore et al. 1999).
The available data do not show the clear superiority of any option concerning ostium
size and location (Woog et al. 2001).
Stenting
To prevent the obliteration of the intranasal lacrimal sac ostium, many surgeons
prefer to insert bicanalicular silicone tubes to stent the rhinostoma (Kong et al. 1994,
Shun-Shin 1998, Szubin et al. 1999). Some authors believe that silicone intubation
after DCR surgery is advisable, while others think it may be a reason for failure
(Unlu et al. 2002). Others object that the silicone tubes keep the lacrimal sac flaps
separate (Kohn 1988). The tube can be fixated by a knot or clip (Wong et al. 1998).
Nonetheless, there is general agreement on using silicone intubation after DCR in
cases with canalicular stenosis (Hurwitz et al. 1989, Walland and Rose 1994).
However, silicone tubing has some disadvantages; it may cause granulation tissue
formation, infection, or canalicular laceration, and the tubing may become dislocated
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from the rhinostomy site (Metson 1990; Walland and Rose 1994), or it may otherwise
cause discomfort to the patient (Unlu et al. 2002, Ressiniotis et al. 2005).
Nasal packing
To achieve hemostasis and prevent scar formation, various materials such as
dissolvable foam, topical hemostatic sealants, or non-resorbable packs have been
tested in the middle meatus after endoscopic nasal surgery (Durrani et al. 2007,
Weitzel and Wormald 2008, Leunig et al. 2009, Szczygielski et al. 2010). However, in
practice non-resorbable packs are most commonly used to achieve postoperative
hemostasis and the effect of these on scar formation remains controversial, and no
long term follow-up data are available (Leunig et al. 2009, Szczygielski et al. 2010).
2.5.2.5 Postoperative care
It is indisputable that postoperative care influences the healing process and is
important for the success of EN-DCR (Kong et al. 1994, Hong et al. 2005).
Postoperative care options include the administration of systemic antibiotics
(Hausler et al. 1999), or a combination of antibiotic-steroid eye drops (Wormald
2002), local irrigation of the rhinostomy site with a saline nasal spray (Woog et al.
1993, Szubin et al. 1999, Unlu et al. 2000), intranasal steroids (Kong et al. 1994, Hehar
et al. 1997), and debridement of the intranasal wound (Kong et al. 1994, Metson et al.
1994, Hartikainen et al. 1998a).
Silicone stent removal
The optimal time for silicone stent retention is still controversial. In published
studies, the recommended time for retaining a stent vary from 4 weeks to 6 months
(Boush et al. 1994, Hehar et al. 1997, Wormald 2002). However, in a review article
Woog et al. (Woog et al. 2001) recommend that a stent should be retained for at least
11-12 weeks.
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Follow-up time
The guidelines of the Royal College of Ophthalmologists suggest that the follow-up
time should be at least three months. Some retrospective studies have reported a 5-
year average follow-up period, but in this case the success rate fell from 88% after
one year to 75% after 5 years (Dietrich et al. 2003). The outcomes of EN-DCR may
decline in long-term follow-up (Nussbaumer et al. 2004).
2.5.2.6 Complications
Several early complications have been identified: intraoperative or postoperative
hemorrhage (Orcutt et al. 1990, Hartikainen et al. 1998a, El-Guindy et al. 2000),
silicone tubing prolapse (Orcutt et al. 1990, Boush et al. 1994), punctal erosion related
to silicone tube use, canalicular obstruction (Sadiq and Downes 1998, Hartikainen et
al. 1998a, Hartikainen et al. 1998b), orbital fat herniation, orbital and subcutaneous
emphysema (Kong et al. 1994, Sprekelsen and Barberan 1996, Sham and van Hasselt
2000), conjunctival fistula formation (Mickelson et al. 1997), retrobulbar hematoma
and temporary ophthalmoplegia (Hehar, et al. 1997). There are rare reports of
cerebrospinal fluid leaks and meningitis following dacryocystostomy (Neuhaus and
Baylis 1983, Beiran et al. 1994, Fayet et al. 2007).
Most of the late complications occur between one and three months after surgery
(Moore et al. 2002). The following late complications after EN-DCR have been
identified in the literature: scar formation of the rhinostoma (Jokinen and Kärjä 1974,
Allen et al. 1988, Boush et al. 1994), synechiae between the rhinostoma and middle
turbinate, rhinostoma and the nasal septum, and the septum and the middle
turbinate, and granuloma formation within the ostium (Hausler and Caversaccio
1998, Fayet et al. 2002).
34
2.5.2.7 Wound healing of nasal mucosa
In  long-term  follow-up,  adhesions  of  the  rhinostoma  site  are  the  most  common
findings which explain the failure after EN-DCR, and this is linked to the biology of
nasal mucosa wound healing (Goldberg 2004).
The precise mechanisms involved in wound healing in the respiratory mucosa
remain unclear. Little information is available regarding the specific wound healing
after surgery in the nasal cavity. The repair prossess of tissue injury typically include
two well-defined stages: a regenerative stage, in which injured cells are replaced by
cells of the same type and the stage of fibrosis, in which connective tissue replaces
normal tissue. The new epithelial cells migrating from the undamaged areas
gradually switch their major function to protein synthesis and are transformed into
myofibroblasts. These play a key role in activating the primary collagen-producting
cells and thus they are cellular mediator of fibrosis. It is know that myofibroblasts are
activated by a variety of mechanisms, including paracrine signals from lymphocytes
and macrophages, and autocrine factors secreted by myofibroblasts. Moreover, many
important regulators of fibrosis have been identified, such as cytokines, angiofgenic
factors, and acute phase proteins (Wilhelm 1953, Georgopoulos and McFarland 1993,
Watelet et al. 2006, Wynn 2008).
If tissue in the vicinity of the wound, has suffered stress stimuli such as heat shock,
viral or bacterial infections, autoimmune inflammatory processes, or certain chemical
exposures, these evoke the expression of highly conserved heat shock proteins
(HSPs). This could affect the migration of epithelial cells, which may delay the
transformation  of  myofibroblasts  and  resulting  in  the  slowing  of  wound  healing
(Georgopoulos and McFarland 1993, Kaarniranta et al. 1998, Kaarniranta et al. 2005,
Salminen et al. 2008).
According to their function or molecular size, the HSP are classified into different
families (HSP90, HSP70, HSP60, HSP40 and small HSPs) (Georgopoulos and
McFarland 1993). HSP47 is closely implicated in fibrotic processes, functioning as a
specific chaperone for procollagen molecules as they transit through the endoplasmic
reticulum (Nagata 1996).
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2.5.2.8 Outcome
The outcome assessments are based on subjective postoperative symptoms and
objective signs. However, in clinical practice there is often a discrepancy between
objective findings and patient’s subjective outcome benefit (Moore et al. 2002,
Goldberg 2004, Yigit et al. 2007).
Objective assessment of outcome
The assessments of objective findings include visual (endoscope evaluation)
(Minasian and Olver 1999, Önerci et al. 2000), quantitative (postoperative
scintigraphy and measurement of lacrimal sac pressure) (Hill et al. 1974,
Malbouisson et al. 1997), anatomic (lacrimal sac irrigation) and functional (functional
endoscopic dye test (FEDT)) outcomes assessments (Moore et al. 2002, Dietrich et al.
2003).
In a prospective study with 69 patients, Moore and colleagues (Moore et al. 2002)
showed that FEDT was useful in assessing rhinostomy patency, but has no
advantage over irrigation in the assessment of symptomatic success. Some studies
suggest a FEDT as a definitive criterion for functional success (Dietrich et al. 2003).
Other  studies  show  that  EN-DCR  influences  the  lacrimal  pump  mechanism  and
changes tear passage (Kamel et al. 2003). The failure of the lacrimal pump is the most
likely cause of continuous epiphora in the presence of a patent rhinostoma and free
(positive FEDT) flow of fluorescein into the nose (Wormald and Tsirbas 2004).
Subjective assessment of outcome
 Subjective assessment includes evaluation of symptom and Quality of Life
questionnaires (Bakri et al. 1999, Holmes et al. 2006). Local symptoms related to
NLDO include tearing, irritation, painful swelling, redness in the lacrimal sac region,
pain in the forehead and nose, discharge of pus and change in vision (Huber-Spitzy
et al. 1992, Bakri et al. 1999, Lee and Woog 2001, Das et al. 2008). However, a
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validated symptom questionnaire exists only for NLDO in children (Holmes et al.
2006). In studies with adults, researchers must make up their own questions
addressing ocular symptomatology related to NLDO symptoms (Bakri et al. 1999).
For measures of symptom severity, one commonly used verbal rating scale consists
of four levels: “cure”,”better”,”no change” and “worse” (Ho et al. 2006). For
quantitative measures of symptom severity, a visual analogy scale (VAS) or numeric
rating scale (NRS), which correlate with each other, must be used (Bijur et al. 2003).
2.5.2.9 Quality of Life
According to the World Health Organization’s definition, “Quality of Life (QoL)
includes psychological and social functioning as well as physical functioning and
incorporates positive aspects of well-being as well as negative aspects of disease or
infirmity” (World Health Organisation 2006). QoL can be measured with generic
quality of life instruments, which are suggested for use in patient groups suffering
from different diseases, and disease-specific tools designed to evaluate patients
suffering from specific diseases.
One generic QoL tool is the Glasgow Benefit Inventory (GBI), which was generated
to measure a change in health status resulting from different types of
otorhinolaryngological interventions. The GBI is quite commonly used for the
measurement of surgical outcomes in rhinological procedures (Chester and Sindwani
2007). The GBI has also been recommended as a feasible tool to compare and
evaluate outcome after endoscopic laser-assisted and external DCR techniques (Bakri
et al. 1999). Ho and co-workers (Ho et al. 2006) used GBI in a prospective study and
found that the non-laser endonasal DCR technique had a positive impact on the
quality of life. In a recently published study, patients were grouped according to
indication for endonasal DCR, and those with mucocele showed greater
improvement in GBI scores than patients with obstruction of the lacrimal system or
dacryocystitis (Spielmann et al. 2009).
37
3 AIMS OF THE STUDY
The aims of the present study were
1. To evaluate the overall surgical outcome after EN-DCR (Studies I-II)
2. To evaluate the surgical outcome after primary EN-DCR at the six-
month follow-up (Studies II-IV)
3. To evaluate the impact of silicone tubes on the outcome after primary
EN-DCR (Study II)
4. To investigate whether there is an association between heat shock
protein (HSP) expression and scar formation in the nasal mucosa in patients
after primary EN-DCR (Study III)
5. To evaluate the impact of successful primary EN-DCR on the symptoms
and the quality of life of the patients (Study IV).
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4 MATERIAL AND METHODS
4.1 Patients
The retrospective study involved all 36 adult patients who had underdone 42 EN-
DCR between July 2000 and August 2004 in Kuopio University Hospital (Study I).
The recruitment for the prospective study (Studies II-IV) started in September 2004,
and ended in May 2008. The participants were consecutively recruited from the adult
patients referred to the outpatient clinic of the Department of Otorhinolaryngology at
Kuopio University Hospital, in Kuopio, Finland because of nasolacrimal pathway
obstruction. The patients were eligible for participation if they were adults (age 18
years or older), were American Society of Anesthesiologist physical status I-III, and
were scheduled for primary lacrimal pathway surgery because of tearing or recurrent
infection of the lacrimal sac. The exclusion criteria were pre-saccal obstruction,
previous nasolacrimal surgery, malignancy in the paranasal sinuses, nasal cavity, or
lacrimal pathway, mental disability, pregnancy or breast feeding.
Study II involved 46 consecutive EN-DCR (four bilateral) for 42 patients. Study III
involved 30 patients from Study II. Study IV included all the patients in Study II and
22 additional patients who had undergone unilateral primary EN-DCR. The
flowchart for Studies II-IV is presented in Figure 7.
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Figure 7. Studies II-IV flowchart.
Study population with Primary EN-DCR
Preoperative visit
Symptom score, endoscopic score, Irrigation of lacrimal sac
Paranasal CT scan
Inclusion
N=64
One week follow-up
N=64
Symptom score, endoscopic score
Irrigation of lacrimal sac
Analyzed
N=58
( 62 EN-DCR )
Two months follow-up
N=64 ( 68 EN-DCR )
Symptom score, endoscopic score
Glasgow Benefit Inventory
Irrigation of lacrimal sac
Six months follow-up
N=63 ( 67 EN-DCR )
Symptom score, endoscopic score
Glasgow Benefit Inventory
Irrigation of lacrimal sac
12 months after EN-DCR
Glasgow Benefit Inventory
sent out by mail
Drop-out
N=1
Drop-out
N=5
Study II
Randomization
N=42
23 EN-DCR
without
silicone tube
23 EN-DCR
with
silicone tube
Study III
HSP 47 intensity in nasal mucosa
N=30
Study IV(+N=22 without silicone tube)
Impact on QoL and symptoms
N=64 ( 68 EN-DCR )
N=number of patients; EN-DCR=endoscopic dacryocystorhinostomy; CT=computer
tomography; HSP=heat shock protein; QoL=quality of life.
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4.2 Methods
All the patients had a preoperative visit and at least three postoperative visits, at one
week,  and  at  2  and  6  months  after  the  surgery  (Studies  I-IV).  In  Studies  II-IV,  the
patients filled out the GBI (Robinson et al. 1996) at two postoperative visits (at 2 and
6 months visits). The same GBI form was mailed twelve months after the surgery to
each patient who had participated in the 6-month follow-up.
Study I investigated outcomes after EN-DCR retrospectively and involved 42 (23
primary and 19 revision) consecutive EN-DCR in 36 adults. Bicanalicular silicone
stents were inserted in 18 operations and in 24 operations no silicone tubes were
used.
Study II was a randomized, prospective, open clinical trial with two parallel groups
of patients with primary EN-DCR. The patients were randomized into two study
groups, EN-DCR either with or without the insertion of a bicanalicular silicone tube.
The allocation was computer-generated and a sealed opaque envelope method was
used to ensure blinding.
Studies III and IV were prospective, open clinical trials and investigated the
expression of HSP 47 in metaplastic nasal mucosa (Study III), and the impact of
primary EN-DCR on the QoL and symptoms (Study IV).
4.3 Preoperative assessment
In Study I, all the patients were examined preoperatively by an ophthalmologist and
an otorhinolaryngologist, and their symptoms before the EN-DCR procedure were
assessed and recorded in the patients’ medical records.
In  Studies  II-IV,  the  clinical  assessments  for  all  patients  were  done  by  an
otorhinolaryngologist and included endoscopic examination of the nasal cavity and
irrigation  of  the  lacrimal  sac,  which  was  performed  to  check  the  patency  of  the
nasolacrimal pathway and to rule out presaccal obstructions. Preoperatively all
patients underwent CT scans to clarify the detailed anatomy of the paranasal sinuses,
the nasal cavity and the lacrimal pathway. Contaminant infections of the paranasal
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sinuses and nasal cavity were carefully treated preoperatively. Findings in the nasal
cavity were assessed and scored by an otorhinolaryngologist using the Lund-
MacKay (Lund and Mackay 1993) staging system (Appendix). The use of
anticoagulation medications was checked carefully and ceased ad hoc if possible
preoperatively.
During the preoperative visit (Studies II-IV), all the patients filled out a Nasolacrimal
Duct Obstruction Symptom Score (NLDO-SS) questionnaire and preoperative data
study forms.
4.4 Surgical methods
In Studies I-IV all the operations were performed under standardized endotracheal
general anesthesia. To provide sufficient topical decongestion and hemostasis, all the
patients received 40 mg/mL cocaine hydrochloride or lidocaine hydrochloride with 1
g/mL epinephrine solution cotton wads 30 minutes before being taken to the
operating theatre, and an injection of 5mg/mL lidocaine with 1 g/mL epinephrine
into the nasal mucosa over the proposed rhinostomy site after endotracheal
intubation.
All the operations in Studies II-IV were performed by the same three experienced
otorhinolaryngologists. Each operation was performed jointly by two of the
surgeons. The assistant surgeon introduced a 20-gauge endoilluminator probe
(Alcon®, Alcon Laboratories, Fort Worth, USA) through the inferior canaliculus into
the lacrimal sac. The location of the lacrimal sac was visualized endonasally by
transillumination. The surgery was done using a 0° 4-mm rigid endoscope (Karl
Storz®, Tuttlingen, Germany) with a video display monitor. In Studies II-IV, the
mucosa over the rhinostomy site was partially removed for histological analysis at
the beginning of the operation and the rest was lifted with a dissector and tucked
medially under the middle turbinate. The rhinostomy was accomplished using a
diamond burr attached to a microdebrider (Xomed®, Medtronic Xomed Surgical
Products, Jacksonville, USA). The lacrimal sac was exposed and opened wide under
endoscopic control. A bicanalicular lacrimal silicone tube (Bernard, Unomedical Ltd.,
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Redditch, UK) was inserted if the patient had been randomized for tubing (StudyII).
Hemostasis was achieved with nasal packing (Merocel®, Medtronic Xomed Surgical
Products, Jacksonville, USA) under the middle turbinate, when needed.
4.5 Histology
In  Study III,  the  histological  samples  from the  nasal  mucosa were  fixed in  formalin
and further processed according to routine protocols. The adequacy of the samples
was confirmed by having the Haematoxylin-Eosin (HE) stained sections analyzed by
an experienced histopathologist. The samples were cut into 5 m thick sections,
which were used in immunohistochemical analyses.
4.6 Immunohistochemistry
In Study III, the sections were deparaffinized in xylene and rehydrated in graded
ethanols according to standard procedures. Endogenous peroxidase was blocked by
3 mg/mL hydrogen peroxide. A histostainTM Plus  Mouse Primary Bulk kit  (Zymed
Laboratories, San Francisco, USA) was used for immunostaining HSP47 (1:100
dilution, Stress, Ann Arbor, USA). The appropriate dilution and the functionality of
the antibody had been tested previously (Razzaque and Taguchi 1997). The negative
controls were processed without the primary antibody, and showed no positivity.
All stainings were analyzed by the same observer, unaware of the clinical data of the
patients. The staining signal for HSP47 was located in the cell cytoplasm. The
staining intensity in the epithelium and stromal tissue was analyzed separately and
was graded as follows: 0=negative, 1=weak, 2=moderate, 3=strong. Strong intensity
was comparable to that seen in negative controls. Because of the heterogeneous
staining intensity found in many slides, a 50% cut-off level was used, i.e. the case was
considered moderately or strongly stained if >50% of the epithelial or stromal cells
showed that intensity.
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4.7 Postoperative treatment and assessments
4.7.1 Postoperative care and objective assessments
In Studies I-IV, during the postoperative period all the patients were treated with
topical dexamethasone and chloramphenicol eye-drops for two week, and intranasal
saline spray for one month. During the first postoperative visit (Studies II-IV), before
irrigation of the lacrimal sac, debridement was performed, i.e. the rhinostoma site
and middle meatus were cleaned with suction by using a nasal endoscope in local
anesthesia (Studies I-IV).
In Study II, the silicone tubes were removed at the second postoperative visit (at two
months after surgery). The objective assessment was done by an
otorhinolaryngologist using a rigid endoscope and lacrimal sac irrigation at each
visit. In Studies II-IV, the objective findings in the nasal cavity were scored using the
Lund-MacKay staging system (Lund and Mackay 1993). The surgical outcome was
considered successful (Studies I-IV) if the saline solution freely reached the nose
during the lacrimal sac irrigation and if the patients had no tearing or recurrent
infection of the lacrimal sac.
4.7.2 Postoperative questionnaires
In  Studies  II-IV,  during each postoperative  visit  the  patients  filled in  the  NLDO-SS
questionnaire, which consists of five items focused on the common ocular symptoms
of NLDO (Bakri et al. 1999), two items describing the conditions in the nasal cavity,
and one item on general condition (Appendix). In the NLDO-SS, the symptoms are
graded using an 11-point numeric rating scale (NRS; 0 = no symptoms, 10 = worst
imaginable symptom). The questions were carefully explained to the patients each
time before they completed the questionnaires, and the answers were checked by the
otorhinolaryngologist during the visit.
The Glasgow Benefit Inventory (Robinson et al. 1996) consists of 18 questions, which
in Studies II-IV were adapted for use with a nasal operation. In the GBI, the response
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to each question is based on a five-point Likert scale (Likert 1932) ranging from a
large deterioration in health status through to a large improvement in health status.
The GBI is scored into a total score and three subscales, each ranging from -100
(maximal negative benefit) through zero (no changes) to +100 (maximal positive
benefit). The subscales consist of a general subscale (12 questions), a social support
subscale (three questions), and a physical health subscale (three questions) (Robinson
et al. 1996).
4.8 Statistical methods
In Studies I-III, differences between groups were assessed with the Pearson Chi-
Square and Fisher’s exact test. The correlations between categorical variables were
assessed with Pearson’s correlation coefficient.
In Study II, twenty-three operations in each group were found to have over 80%
power to demonstrate a difference of 35% between the successful and failed
procedures in each group when the two-sided level of staistical significance was set
to 5%.
In Study IV, repeated measures analysis of variance between groups was used to
study the differences between the measurement time points. Post hoc tests were based
on estimated marginal means and were Bonferroni corrected. Correlations between
variables were assessed with Spearman’s correlation coefficient.
In Studies I-IV, 95% confidence intervals (CI) were calculated for the main results,
and all the analyses were performed on an intent-to-treat basis. Differences were
regarded as statistically significant if a two-sided P-value was less than 0.05. Data are
expressed as the number of cases or mean with standard deviation (SD). Patient
characteristics and variables were analyzed with the Statistical Package for Social
Sciences (SPSS software version 11.5-17.0 for Windows, SPSS Inc., Chicago, USA).
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4.9 Ethical aspects
The study was approved by the Research Ethics Committee of the Hospital District of
Northern Savo, Kuopio, Finland (decision number 59/2004) and it was conducted in
accordance with the Declaration of Helsinki (The World Medical Association (WMA)
1998). The patients were given oral and written information about the trial protocol
and they provided written consent.
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5 RESULTS
In the prospective Studies II-IV, all 64 patients (68 operations) presented at the one-
week  and  two-month  follow-up  visits.  One  patient  died  4  months  after  surgery
(cerebral palsy, not related to surgery) and thus the 6-month follow-up visit data
involved 63 patients and 67 operations. Five patients did not respond to the 12 month
questionnaire, and thus the 12 month follow-up data were available for 58 patients
(62 operations).
Bilateral surgery was performed in four patients. Additional surgery for
abnormalities in the nasal cavity interfering with the operation, such as septal
deviation (three patients), hypertrophic middle turbinate resection (two patients) or
infundibulotomy (two patients), was performed in seven patients.
5.1 Surgical outcome (Studies I-IV)
In the combined study population (Studies I-IV), the overall success rate after EN-
DCR was 89% (98/110 operations), and the overall success rate after primary EN-
DCR was 88% (79/90 operations).
The success rate of primary EN-DCR (Studies I-II) with silicone tubing was 80%
(28/35 operations), and 91% (30/33 operations) without tubing.
In the observational follow-up study (Study I) of 36 patients with 42 operations, the
overall success rate after EN-DCR was 36 out of 42 (81%) operations. The success rate
with silicon tubing was 16 out of 18 operations, and without tubing it was 18 out of
24 operations (mean difference 14%, 95% CI of the difference; 10 to 38%, p = NS,
Fisher’s exact test). Primary surgery was successful in 17/23 (74%) operations, 10/12
(83%) with silicone tubing and 7/11 (64%) without tubing. Revision surgery was
successful in 17/19 (89%) operations; 6/6 (100%) with silicone tubing and 11/13
(85%) (p = NS) without tubing.
In the prospective study (Studies II-IV), the overall success rate after primary EN-
DCR at the six-month follow-up was 62 out of 67 (93%) operations. At the two-month
follow-up visit, each patient’s rhinostoma was open (Study II). At the six month
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follow-up visit, the rhinostomas of all primary EN-DCR without silicone tubing
23/23 (100%) were open, whereas in the silicone tubing group the rhinostomas were
open in only 18/23 (78%) of operations (mean difference 22%, 95% CI of the
difference; 4 to 40%, p<0.049).
5.2 Expression of HSP 47 in nasal mucosa (Study III)
Histopathological evaluation
In 10 out of 30 patients, squamous metaplasia was noted on the surface epithelium
associated with the mild chronic lymphoplasmacytic inflammation in the stroma
surrounding the mucus-secreting glands (Figure 8A). Squamous metaplasia in the
surface epithelium was associated with unsuccessful EN-DCR (P = 0.031).
A positive expression of HSP47 was noted both in the cells of the surface
pseudostratified epithelium and in the columnar epithelium of the stromal glands. A
metaplastic change in the surface epithelium was associated more often with
moderate or strong expression of HSP47 (Figure 8B). In the samples with metaplasia,
moderate or strong stromal expression for HSP47 was found in 8/10 patients (P =
0.02). All cases with failed outcome showed either strong or moderate expression of
HSP47 (P = 0.014).
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Figure 8 A-B. Histopathology of the nasal mucosa.
A. Hematoxylin-eosin section of the nasal mucosa showing squamos metaplasia in
the surface epithelium (circle).
B. Immunohistochemial staining demonstrating strong expression of HSP47 in the
metaplastic epithelium (circle). HSP47 expression is also noted in stromal cells
(arrows). Bar = 50m.
A
B
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5.3 Impact on quality of life and symptom changes (Study IV)
5.3.1 Quality of life
All three questionnaires were fully completed by 58 of 63 (92 %) patients. A
significant benefit from the EN-DCR was observed at all three times of assessment.
At two months, the GBI scores were higher in all three subsets, and between the two-
and six-months assessments a further gain was reported in the general and physical
subsets (P = 0.001) (Table I).
Table I. Distribution of GBI scores by subsets at two and six months after EN-DCR.
                                               Two months                    Six months
                                       Mean scores (95% Confidence Intervala)                        P - value
Total GBI score                +37.0 *(29.7-44.2)                 +52.3 * (45.1-59.5)                     0.001
General subset score       +36.4 * (28.8-43.9)                +53.0* (45.7-60.2)                      0.001
Physical subset score      +39.6 * (31.5-47.6)                +56.0 * (47.5-64.5)                     0.001
Social subset score           +36.8 (27.8-45.9)                  +46.1 (37.0-55.2)                       0.192
* The mean difference is significant at the P=0.05 level
a. Adjustment for multiple comparisons: Bonferroni.
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5.3.2 Nasolacrimal Duct Obstruction Symptom Score (NLDO-SS)
EN-DCR resulted in  a  significant  reduction in  all  of  the  eight  items:  the  mean total
score fell from 38 points (SD 13) at baseline to 10 (10) points (mean difference 28, 95%
CI 23-33, P = 0.001) at six months (Figure 9). The greatest reduction was detected in
the five ocular symptoms, in which the mean score decreased from 26 points (9) at
baseline to 5 (7) points (P = 0.001) at 6 months (Figure 10).
Figure 9. Total Nasolacrimal Duct Obstruction Symptoms Score (NLDO-SS) at
baseline and three assessment times after EN-DCR.
Data are mean with standard error (s.e.)
* Statistically significant difference, P=0.001
EN-DCR= endoscopic dacryocystorhinostomy
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Figure 10. The mean scores of five ocular symptoms at baseline and at three
assessment times after EN-DCR.
Data are mean with standard error (s.e.)
* Statistically significant difference P=0.001
EN-DCR = endoscopic dacryocystorhinostomy
5.3.3 Correlations
The correlations of GBI, NLDO-SS and Endoscopic Lund-MacKay Score were
calculated for the two- and six-month’s postoperative visits. There was a negative
correlation between total GBI and NLDO-SS (r = -0.314, P = 0.009; r = -0.394, P =
0.001, respectively). A negative correlation was found between total GBI and
Endoscopic Lund-MacKay Score at six months after operation (r = -0.258, P = 0.037),
and a positive correlation between Endoscopic Lund-MacKay and NLDO-SS at two
and six month’s postoperative visits (r = 0.289, P = 0.017; r = 0.245, P = 0.046,
respectively). There were no correlations between total GBI, Endoscopic Lund-
MacKay and NLDO-SS at two months after operation (P = NS) (Table II).
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Table II. Correlation between Glasgow Benefit Inventory, Nasolacrimal Duct
Obstruction Symptom Score (NLDO-SS) and Endoscopic Lund-MacKay Score at two
and six months after EN-DCR.
                                                                            At two months                           At six months
                                                                            after EN-DCR                             after EN-DCR
                                                                            r - value        P -value                  r -value         P -value
Variable
Total GBI score <=> NLDO-SS                       -0.314**      0.009                       -0.394**           0.001
Lund-MacKay score <=> NLDO-SS                0.289*        0.017                        0.245              0.046
Total GBI score <=> Lund-MacKay score       0.658         0.055                       -0.258*             0.037
r=correlation coefficient
** Correlation is significant at the 0.01 level (2-tailed)
  *Correlation is significant at the 0.05 level (2-tailed)
EN-DCR= endoscopic dacryocystorhinostomy
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6 DISCUSSION
Although EXT-DCR is still considered to be the “gold standard” (Tarbet and Custer
1995a), this study shows that EN-DCR is an effective and safe treatment for post-
saccal obstruction of the nasolacrimal pathway. The standard procedure for DCR has
involved stenting the rhinostoma with a silicone tube at the end of the operation
(Gauba et al. 2008). However, the prospective part of this study reveals that silicone
tubes do not provide any further benefits. Moreover, in this study successful EN-
DCR had a positive impact on the patients' well-being. This study also confirms that
adhesions of the rhinostomy site are the main cause of EN-DCR failure and that
preoperative histopathological changes in the nasal mucosa may affect the final
outcome.
6.1 Overall success of EN-DCR
In the combined study population (Studies I-II), the overall success rate after EN-
DCR was 89% (98/110 operations). However, the success rate in the prospective
study was higher than in the retrospective study (93% vs. 81%). This may be
explained by an effect of the learning curve and the use of the same standard
technical approach.
The results in our trial are well in line with those of earlier studies assessing the effect
of EN-DCR, where the success rate has varied between 83% (Jokinen and Kärjä 1974)
and 96% (Sprekelsen and Barberan 1996).
Outcomes after EN-DCR and EXT-DCR were comparable, with good results
maintained over time. A recent retrospective comparison of outcomes between EN-
DCR and EXT-DCR showed that the success rate (94%) for EXT-DCR is slightly better
than that (86%) for EN-DCR (Leong et al. 2010b). The success rate of microscopic
endonasal DCR including laser procedures has varied between 80 and 88% (Hausler
and Caversaccio 1998, Dietrich et al 2003). A prospective randomized comparison of
EXT-DCR and EN-DCR with the CO2-Nd: YAG laser reported a 91% success rate for
the external approach compared with 75% for the endonasal technique (Hartikainen
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et al. 1998a). However, Leong and co-workers (2010a), in a systematic review of
outcomes after DCR in adults, showed that the failure rate for laser-assisted DCR
was higher.
6.2 Use of silicone tubing
The studies evaluating the effect of silicon tubes after EN-DCR have shown
considerable inconsistency. There are studies that demonstrate favorable effects of
silicone tubing, such as the prevention of the obliteration of the rhinostomy site,
leading to more successful EN-DCR (Kong et al. 1994, Shun-Shin 1998, Szubin et al.
1999, Wu et al 2009a). On the other hand, other studies have reported that the
omission of silicone tubes does not increase the risk of obliteration (Mortimore et al.
1999, Unlu et al. 2000, Unlu et al. 2002, Ressiniotis et al. 2005). Although the use of
silicone tubing after EN-DCR has been widely recommended (Woog et al. 1993,
Boush et al. 1994, Weidenbecher et al. 1994) no randomized controlled studies have
been carried out on the effects of silicone tubes.
This is the first randomized controlled study on the effect of silicone tubes after
primary  EN-DCR,  and  it  did  not  detect  any  benefit.  Furthermore,  all  failures  were
found in patients who had undergone silicone intubation after EN-DCR. In the
patients suffering a failure, tearing recurred during the four weeks after the removal
of  the  silicone  tubes.  It  was  observed  that  the  main  reason  for  failures  was  the
formation of scar tissue obscuring the rhinostomy site. Based on our findings, the
insertion of silicone tubes is not recommended after primary EN-DCR.
6.3 Quality of life and symptoms after primary EN-DCR
In the present study, primary EN-DCR was found to result in marked improvements
in QoL and in symptoms related to obstruction of the nasolacrimal duct. Moreover, a
correlation between the GBI and NLDO-SS questionnaire was found, which together
proved to be more effective than the GBI alone for the assessment of outcome after
endonasal dacryocystorhinostomy. Our finding supports those of previous studies
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reporting a positive impact on QoL related to EN-DCR (Bakri et al. 1999, Ho et al.
2006, Spielmann et al. 2009). Our trial indicates that successful primary EN-DCR has
a significant impact on the patients' QoL, and the health benefits improved
significantly up to six months after operation. The NLDO-SS questionnaire proved to
be reliable, sensitive and simple to use for EN-DCR patients, and together with the
GBI gives more information about the outcome after a nasolacrimal intervention than
the GBI alone.
6.4 Risk factors for failure in EN-DCR
Several prognostic factors may affect the outcome of primary EN-DCR. Önerci and
co-workers demonstrated that EN-DCR is a relatively infrequent operation, with an
obvious learning curve. Thus, experience plays an important role in the success of the
procedure (Önerci et al. 2000). Therefore, less experienced surgeons performing the
procedure infrequently and alone increase the risk of failure. In the present study all
operations were performed by three experienced surgeons. Moreover, the teamwork
of two surgeons worked well.
A history of chronic or recurrent sinusitis, or additional nasal surgery at the same
time with EN-DCR, has been shown to increase the risk of EN-DCR failure (Allen et
al. 1988, Nussbaumer et al. 2004). Our results show (Study IV) that patients who had
pre- or postoperative infection in the nasal cavity or sinuses, and those who
underwent additional surgery at the same time as EN-DCR, were at risk to develop
an obstruction between 6 and 12 months after the operation.
A postoperative infection (Osguthorpe and Calcaterra 1979, Osguthorpe and Hoang
1991, Allen and Berlin 1989) also endangers the normal healing process and surgical
outcome  of  EN-DCR,  so  postoperative  care  and  the  timing  of  the  postoperative
follow-up visits are considered to be a crucial factor for the success of DCR (Kong et
al. 1994, Hong et al. 2005). In the present study, we adhered to the recommendation
to clean the rhinostomy site one week after operation (Kong et al. 1994, Metson et al.
1994, Hartikainen et al. 1998a) and performed the local irrigation of the nasal cavity
with saline spray (Woog et al. 1993, Szubin et al. 1999, Unlu et al. 2000) and
56
antibiotic-steroid eye drops for two weeks postoperatively (Wormald 2002).
However, sometimes, regardless of the surgeon’s experience, a meticulously
executed operation and postoperative care, the outcome may still not be satisfactory.
The cause of failure can also be situated at the cell level of the nasal mucosa
(Goldberg 2004).
The nasal cavity is normally covered by ciliated columnar pseudostratified
epithelium. The epithelium consists of three main cell types: ciliated cells, goblet cells
and basal cells. However, alterations in the epithelium occur from pseudostratified
portions to ciliated columnar, simple cuboidal and metaplastic change. These cellular
changes are considered to be adaptive, controlled by different exposures. The
histopathological changes of the nasal mucosa are induced by different toxins, gas,
chemical evaporations, smoking, allergy, or recurrent or chronic inflammation of
nasal mucosa. All these irritants increase the risk of developing metaplasia in the
surface of the nasal mucosa (Skoloudik et al. 2009, Hadar et al. 2009, Lei et al. 2010).
However, no data regarding the importance of squamos metaplasia in the surface
epithelium in asymptomatic person are available. This is because it is difficult to see
the macroscopic difference between squamos metaplasia and normal nasal mucosa.
Because squamos metaplasia alone is non-symptomatic, the histopathological
changes of the nasal mucosa are observed incidentally when performing a biopsy for
some other reasons. On the other hand, squamos metaplasia may be temporary and
disappear when the effects of the irritants stop, and the structure of the surface
epithelium returns to normal.
In order to evaluate the factors related to wound healing and possibly affecting the
final outcome of primary EN-DCR, we analyzed the preoperative histopathological
changes of the nasal mucosa. Squamous metaplasia in the surface epithelium was
associated with unsuccessful EN-DCR. It was observed in the follow-up that patients
with metaplasia in the surface epithelium also had either scar or granulation tissue
over the rhinostomy site. Moreover, all cases with failed outcome showed either
strong or moderate expression of HSP47, which is implicated in the molecular
maturation of various types of collagens.
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The present study demonstrates that both preoperative metaplastic changes and
strong expression of HSP47 in nasal mucosa predict scar tissue formation after
primary EN-DCR. Moreover, if both of these predictors are present, the risk of failure
seems to be even higher. These findings open a new perspective for exploring the
regulation  of  inflammation  and  fibrosis  in  the  nasal  mucosa,  which  might  uncover
novel predictors of outcomes for operations in the nasal cavity. HSP47 is a promising
focus  for  future  studies  as  a  potential  target  for  developing  anti-fibrotic  therapy  in
different surgical problems or diseases to prevent scar formation. Further studies are
needed to clarify whether these predictors have any implications for operative
techniques and preoperative and postoperative treatments in patients with NLDO.
6.5 Limitations of the present study
The number of patients in the present study was not extensive, as has been the case
in most other studies concerning EN-DCR. This probably results from the relatively
small number of EN-DCR operations performed in single centers. The problem is
statistically exaggerated when patients are divided into smaller subgroups within a
study.
The objective findings in the nasal cavity were scored using the Lund-MacKay
staging system (Lund and Mackay 1993). As was to be expected, a statistically
significant difference was found between the preoperative and one-week
postoperative Lund-MacKay Endoscopic score, but after mucosa healing we did not
find any difference in scores. Moreover, objective assessment and scoring of the
postoperative condition in the nasal cavity depends on the individual scorer.
Although  the  results  regarding  the  necessity  of  silicone  tubing  are  promising,  they
need to be replicated in larger studies. Furthermore, a longer follow-up time than six
months may give more reliable objective outcome information.
In the present study the completion of the 12 months GBI questionnaire at home
turned out to be difficult for the study population, which consisted of elderly
patients. Several patients had misunderstood the questions when answering them by
themselves without guidance. To prevent misunderstanding of the questionnaire, we
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recommend that patients complete the quality of life questionnaire during the
follow-up visit.
EN-DCR operations are performed endonasally, whereas the main causes of
complaints in patients with NLDO are in the ocular region. NLDO-SS correlates well
with the GBI and Lund-MacKay score, but the NLDO-SS questionnaire needs further
validation in future prospective randomized studies.
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7 CONCLUSIONS
1.  EN-DCR is an effective procedure with an overall success rate of 89%.
2.  Primary EN-DCR is a highly successful surgical procedure with an
overall success rate of 93% at the six-month follow-up.
3. The insertion of silicone tubes after primary EN-DCR operations does
not contribute any benefit.
4. Squamous metaplasia in the surface epithelium of the nasal mucosa and
strong expression of HSP47 independently or together predict scarring of the
rhinostomy site.
5.  Successful primary EN-DCR seems to have a significant positive impact
on the patients' symptoms and QoL.
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APPENDIX:
Preoperative Data
Nasolacrimal Duct Obstruction Symptom Score Questionnaire (NLDO-SS)
Endoscopic Dacryocystorhinostomy: objective assessements
Surgery Form
Glasgow Benefit Inventory Questionnaire
Original publications I – IV
PREOPERATIVE DATA patient number _________________
ENDOSCOPIC DACRYOCYSTORHINOSTOMY
NAME Tel:
Gender: ___________________________ Height/weight: ___________________________
Smoking 1 Yes 2 No
Predisposing medical condition: ___________________________________________________________
______________________________________________________________________________________
Medication during the last two weeks:
______________________________________________________________________________________
Have you taken medicine for nasolacrimal system disorder?
During the last 3 months?
1. Yes, how many times?_____________________________________ _______
2. No
During the last 12 months
1. Yes, how many times?______________________________________
2. No
Have you undergone a nasolacrimal procedure?
                      During the last 12 months         During the last 3 years
1. Yes, ______times          1. Yes, ______times
2. No         2. No
Have you been treated for rhinosinusitits?
1. Yes,_______times
2. No
Have you been on sick-leave because of nasolacrimal problems?
                      During the last 3 months           During the last 12 months ___________
1. Yes, ______days 1. Yes, ________days
2. No 2. No
Do you think that your working capacity has been compromised?
During the last 3 months            During the last 12 months __________
1. Yes, ______days 1. Yes, ________days
2. No 2. No
   Patient’s name: _______________________________             Patient number__________
                                  NASOLACRIMAL DUCT OBSTRUCTION SYMPTOM SCORE
                                                         QUESTIONNAIRE (NLDO-SS)
PATIENTS’SYMPTOMS (patients fill in themselves)
SYMPTOM BEFORE
EN-DCR
ONE
WEEK
AFTER
EN-DCR
TWO
MONTHS
AFTER
EN-DCR
SIX MONTHS
AFTER
EN-DCR
TEARING
DISCHARGE IN THE
EYE/EYES
SWELLING AROUND THE
EYE/EYES
PAIN AROUND THE
EYE/EYES
CHANGE IN VISUAL ACUITY
NOSE BLOCKAGE
NASAL CAVITY
DISCHARGE
GENERAL CONDITION
TOTAL SCORE
OTHER SYMPTOMS:____________________________________________________
SCORING:
Grade your symptoms numerically on a scale from 0 to 10
(0 = no symptoms, 10 = worst imaginable symptom)
Thank you!
 ENDOSCOPIC DACRYOCYSTORHINOSTOMY: OBJECTIVE ASSESSEMENTS
clinical findings at the preoperative and follow-up visits (filled in by an otorhinolaryngologist)
FINDINGS IN NASOENDOSCOPY
BASELINE
1
 WEEK
2
MONTHS
6
MONTHS
POLYPS, DX
POLYPS, SIN
OEDEMA, DX
OEDEMA, SIN
SECRETIONS, DX
SECRETIONS, SIN
SYNECCHIAE, DX*
SYNECCHIAE, SIN*
CRUSTING, DX *
CRUSTING, SIN
TOTAL SCORE
Other findings:______________________________________________________
SCORING: For polyps: 0=none, 1=in the middle meatus, 2= extending outside the middle meatus.
For the odema, synecchiae and crusting: 0=none, 1=mild, 2= severe.
For secretions: 0=none, 1= light, non-putulent discharge, 2=thick, purulent discharge.
Only for postoperative assessment (Endoscopic Lund-MacKay Score).
EVALUATION OF NASOLACRIMAL DRAINAGE
BASELINE
1
WEEK
2
MONTHS
6
MONTHS
IRRIGATION, dx
IRRIGATION,sin
FLUORECEIN DYE
TEST,dx
FLUORECEINDYE
TEST,sin
SCORING: 0= no obstruction (solution /fluorescein drains freely into the nasal cavity), 1=obstruction
(solution reflux through the opposite punctum/no fluorescein in nasal cavity)
Laboratory culture:________________________________________________
                                                           PREOPERATIVE CT-FINDINGS
SINUS DEXTER SINISTER
MAXILLARY SINUS
ETHMOIDAL SINUSES
BONY NASOLACRIMAL DUCT
LACRIMAL SAC
TOTAL SCORE:
SCORING:For sinuses: 0=normal aeration, 1=partial opacisication, 2=total opacisication
For bony nasolacrimal duct: 0= unobstructed, 1= partial stenosis, 2= total stenosis
For lacrimal sac: 0= normal size, 1= partially cicatrized, 2= totally cicatrized, 3= dilatated.
SURGERY FORM patient number _________________________
ENDOSCOPIC DACRYOCYSTORHINOSTOMY
NAME:_________________
Date of surgery:__________
ASA class    1    2    3    4    5
Operative diagnosis 1. Chronic dacryocystitis 2. Chronic dacryostenosis 3. Other, specify:_______________
___________________________________________________________________________
Operation
1.DCR without silicone tube 2.DCR with silicone tube 4. Revision with  MMC 5.Revision without mitomycin MMC
Additional surgery:
1. Uncinectomy 2. Middle meatal antrostomy 3. 1+2 4. 1+2 and polypectomy 5. Other; specify
_______________________________________________
Surgeon: ___________
Beginning of surgery time:___________
End of surgery time:___________
Supplemental anaesthesia during surgery 1. No 2. Yes, specify___________________
_______________________________________________________________________________
Bleeding:                                     1. No bleeding
2. Less than usual
3. Normal
4. More than usual
5. Other, specify?
Amount of bleeding: Total________ ml
Hemostasis: 1. None
2. Packing
3. Electrocoagulation
4. Packing and electrocoagulation
5. Other, specify?  ____________________________________________
Glasgow Benefit Inventory Questionnaire
1. Has the result of the nasolacrimal operation affected the things you do?
Much A little or No A little or Much
worse somewhat worse change somewhat better better
 1 2  3 4 5
2. Have the results of the nasolacrimal operation made your overall life better or worse?
Much A little or No A little or Much
better somewhat better change somewhat worse worse
5 4 3 2 1
3. Since your nasolacrimal operation, have you felt more or less optimistic about the future?
 Much more More No Less Much less
optimistic optimistic change optimistic optimistic
5 4 3 2 1
4. Since your nasolacrimal operation, do you feel more or less embarrassed when with
a group of people?
 Much more More No Less Much less
 embarrassed embarrassed change embarrassed embarrassed
1 2 3 4 5
5. Since your nasolacrimal operation, do you have more or less self-confidence?
 Much more More No Less Much less
 self-confidence self-confidence change self-confidence self-confidence
5 4 3 2 1
6. Since your operation/intervention*,  have  you  found  it  easier  or  harder  to  deal  with
company?
Much Easier No Harder Much
easier change harder
5 4 3 2 1
7. Since your nasolacrimal operation/intervention*, do you feel that you have more or less
support from
your friends?
8. Have you been to your family doctor, for any reason, more or less often, since your
nasolacrimal operation/intervention*?
Much more More No Less Much less
often often change often often
1 2 3 4 5
9. Since your nasolacrimal operation/intervention*,  do  you  feel  more  or  less  confident  about
job opportunities?
Much More No Less Much less
 more confident confident change confident confident
5 4 3 2 1
10. Since your nasolacrimal operation/intervention*, do you feel more or less self-conscious?
 Much more More self- No Less Much less
 self-conscious conscious change self-conscious self conscious
1 2 3 4 5
11. Since your nasolacrimal operation/intervention*, are there more or fewer people who really
care about you?
Many More No Fewer Many
 more people people change people fewer people
5 4 3 2 1
12. Since you had the nasolacrimal operation/intervention*, do you catch colds or infections
more or less often?
Much more More No Less Much less
often often change often often
1 2 3 4 5
13. Have you had to take more or less medicine for any reason, since your nasolacrimal
operation?
14. Since your nasolacrimal operation, do you feel better or worse about yourself?
Much Better No Worse Much
better change worse
5 4 3 2 1
15. Since your nasolacrimal operation,  do you feel  that  you have had more or  less  support
from your family?
 Much more More No Less Much less
 support support change support support
5 4 3 2 1
16. Since your nasolacrimal operation, are you more or less inconvenienced by your health*
problem?
Much more More No Less Much less
 inconvenienced inconvenienced change
 inconvenienced inconvenienced
1 2 3 4 5
17. Since your nasolacrimal operation, have you been able to participate in more or fewer
social activities?
Many more More No Fewer Many fewer
activities activities change activities activities
5 4 3 2 1
18. Since your nasolacrimal operation, have you been more or less inclined to withdraw
from social situations?
Much more More No Less Much less
inclined inclined change inclined inclined
1 2 3 4 5
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Endoscopic dacryocystorhinostomy 
has become accepted treatment for 
patients with saccal and post-saccal 
obstructions of the lacrimal system. 
In this study the surgical outcome 
after two endoscopic dacryocystorhi-
nostomy surgical techniques, with 
and without the use of lacrimal 
silicone tubes were investigated. In 
addition, the relationship between 
the preoperative conditions of nasal 
mucosa and final outcome of surgery 
was evaluated. This dissertation also 
provides new information about ef-
fect of preoperative changes in nasal 
mucosa on surgical outcome and the 
role of heat shock protein 47 (HSP47) 
expression in scar formation of the 
nasal mucosa.
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